CA988420A - Direct radioimmunoassay for antigens and their antibodies - Google Patents

Direct radioimmunoassay for antigens and their antibodies

Info

Publication number: CA988420A
Authority: CA; Canada
Prior art keywords: antigens; antibodies; direct radioimmunoassay; radioimmunoassay; direct
Prior art date: 1971-12-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA158,644A

Other languages

English (en)

Other versions

CA158644S (en

Inventor

Chung-Mei Ling

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott Laboratories

Original Assignee

Abbott Laboratories

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-12-21

Filing date

1972-12-12

Publication date

1976-05-04

1972-12-12 Application filed by Abbott Laboratories filed Critical Abbott Laboratories

1976-05-04 Application granted granted Critical

1976-05-04 Publication of CA988420A publication Critical patent/CA988420A/en

Status Expired legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA158,644A 1971-12-21 1972-12-12 Direct radioimmunoassay for antigens and their antibodies Expired CA988420A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US210510A US3867517A (en)	1971-12-21	1971-12-21	Direct radioimmunoassay for antigens and their antibodies

Publications (1)

Publication Number	Publication Date
CA988420A true CA988420A (en)	1976-05-04

Family

ID=22783190

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA158,644A Expired CA988420A (en)	1971-12-21	1972-12-12	Direct radioimmunoassay for antigens and their antibodies

Country Status (13)

Country	Link
US (1)	US3867517A (fr)
AT (1)	AT326818B (fr)
AU (1)	AU470050B2 (fr)
BE (1)	BE793061A (fr)
CA (1)	CA988420A (fr)
CH (2)	CH568061A5 (fr)
DE (1)	DE2262413B2 (fr)
FR (1)	FR2164705B1 (fr)
GB (1)	GB1414480A (fr)
IT (1)	IT988084B (fr)
NL (1)	NL7217371A (fr)
PH (1)	PH13655A (fr)
ZA (1)	ZA728798B (fr)

Families Citing this family (884)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4012494A (en) *	1971-12-21	1977-03-15	Abbott Laboratories	Direct radioimmunoassay for antigens and their antibodies
US3949064A (en) *	1973-10-26	1976-04-06	Baxter Laboratories, Inc.	Method of detecting antigens or antibodies
US4172117A (en) *	1974-05-20	1979-10-23	Biotest-Serum-Institut Gmbh	Method for the simultaneous measurement of antigens and their antibodies by solid-phase radioimmunoassay
US3959650A (en) *	1974-08-26	1976-05-25	Intelcom Rad Tech	Method for detecting and identifying allergy
DK140815B (da) *	1975-06-10	1979-11-19	Weeke Bengt	Fremgangsmåde til påvisning eller bestemmelse af antistoffer i legemsvæsker ved hjælp af kendte antigener eller til bestemmelse af antigener ved hjælp af kendte antistoffer fra legemsvæsker samt et middel til anvendelse ved udøvelse af fremgangsmåden.
US4034072A (en) *	1975-07-21	1977-07-05	Corning Glass Works	Serum hepatitis test
USRE32696E (en) *	1975-09-04	1988-06-14	Akzona Incorporated	Enzymatic immunological method for determination of antigens and antibodies
US4642285A (en) *	1975-09-29	1987-02-10	Diamedix Corporation	Sandwich EIA for antigen
US4474878A (en) *	1975-09-29	1984-10-02	Cordis Laboratories, Inc.	Sandwich EIA for antigen associated with hepatitis
SE7610683L (sv) *	1975-09-29	1977-06-10	Cordis Corp	Metod for bestemning av nervaron av ett antigen associerat med hepatit
GB1533272A (en) *	1976-02-13	1978-11-22	Radiochemical Centre Ltd	Centrifuge tube
JPS5851000B2 (ja) *	1976-04-16	1983-11-14	アボツトラボラトリ−ズ	スルホリトコリルグリシルチラミンの製造法
US4272510A (en) *	1976-04-26	1981-06-09	Smith Kendall O	Magnetic attraction transfer process for use in solid phase radioimmunoassays and in other assay methods
US4120945A (en) *	1976-07-06	1978-10-17	Becton, Dickinson & Company	Substrate coated with receptor and labeled ligand for assays
US4210418A (en) *	1976-08-30	1980-07-01	Mallinckrodt, Inc.	Container for immunochemical and enzymatical determinations or procedures
GB1572220A (en) *	1976-10-07	1980-07-30	Mochida Pharm Co Ltd	Immunochemical process of measuring physiologically active substances
US4090850A (en) *	1976-11-01	1978-05-23	E. R. Squibb & Sons, Inc.	Apparatus for use in radioimmunoassays
CA1100037A (fr) *	1977-03-11	1981-04-28	Chung-Mei Ling	Antigene (anti hb.sub.c) depose sur une substance en phase solide
US4200613A (en) *	1977-06-03	1980-04-29	Ramco Laboratories Inc.	Radioimmunoassay apparatus
US4225575A (en) *	1978-05-15	1980-09-30	Ventrex Laboratories, Inc.	Method and apparatus for performing in vitro clinical diagnostic tests using a solid phase assay system
US4197287A (en) *	1977-06-10	1980-04-08	Ventrex Laboratories Inc.	Method and apparatus for performing in nitro clinical diagnostic tests using a solid phase assay system having special utility for use with automatic pipetting equipment
US4320087A (en) *	1978-01-23	1982-03-16	Abbott Laboratories	Laboratory assay device
US4256629A (en) *	1978-02-06	1981-03-17	Research Corporation	Antigen for early pregnancy test and contraceptive vaccine
US4451434A (en) *	1978-03-27	1984-05-29	Hiram Hart	Transparent optical container for non-destructive biological fluid assay
US4189464A (en) *	1978-05-05	1980-02-19	Institute For Cancer Research	Hepatitis B testing reagent and method
US4292403A (en) *	1978-08-24	1981-09-29	Akzona Incorporated	Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins
US4293538A (en) *	1979-04-20	1981-10-06	Merck & Co. Inc.	Assay for hepatitis A antigen
US4356164A (en) *	1979-05-21	1982-10-26	Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services	Detection of non-A, non-B hepatitis associated antigen
US4289748A (en) *	1979-05-31	1981-09-15	United States Of America	Ultrasensitive enzymatic radioimmunoassay method
CA1148859A (fr) *	1979-06-14	1983-06-28	Lacy R. Overby	Technique pour le depistage simultane de deux virus de l'hepatite dans un milieu solide
US4378344A (en) *	1979-09-28	1983-03-29	Ventrex Laboratories, Inc.	Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
EP0111762B1 (fr) *	1980-06-20	1987-11-19	Unilever Plc	Procédés et appareil pour l'exécution d'essais de liaisons spécifiques
US6406920B1 (en)	1980-06-20	2002-06-18	Inverness Medical Switzerland Gmbh	Processes and apparatus for carrying out specific binding assays
US4363634A (en) *	1980-07-18	1982-12-14	Akzona Incorporated	Glass support coated with synthetic polymer for bioprocess
US4357142A (en) *	1980-07-18	1982-11-02	Akzona Incorporated	Glass support coated with synthetic polymer for bioprocess
US4376110A (en) *	1980-08-04	1983-03-08	Hybritech, Incorporated	Immunometric assays using monoclonal antibodies
US4486530A (en) *	1980-08-04	1984-12-04	Hybritech Incorporated	Immunometric assays using monoclonal antibodies
WO1982001773A1 (fr) *	1980-11-07	1982-05-27	Secher David S	Analyse pour l'interferon
US4474892A (en) *	1983-02-16	1984-10-02	Board Of Trustees Of The Leland Stanford Junior University	Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
US4563184A (en) *	1983-10-17	1986-01-07	Bernard Korol	Synthetic resin wound dressing and method of treatment using same
US5158769A (en) *	1984-03-07	1992-10-27	New York Blood Center, Inc.	Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5204096A (en) *	1984-03-07	1993-04-20	New York Blood Center, Inc.	Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US4847080A (en) *	1984-03-07	1989-07-11	New York Blood Center, Inc.	Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
US4861588A (en) *	1985-02-05	1989-08-29	New York Blood Center, Inc.	Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US4804626A (en) *	1986-10-22	1989-02-14	The General Hospital Corporation	Immunometric assay for the detection of human chorionic gonadotropin
US5061619A (en) *	1987-11-05	1991-10-29	Connaught Laboratories Limited	Immunoassay using antibody-antigen conjugates
US5614504A (en) *	1990-08-01	1997-03-25	The University Of South Florida	Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6168956B1 (en)	1991-05-29	2001-01-02	Beckman Coulter, Inc.	Multiple component chromatographic assay device
US5877028A (en) *	1991-05-29	1999-03-02	Smithkline Diagnostics, Inc.	Immunochromatographic assay device
US5998220A (en) *	1991-05-29	1999-12-07	Beckman Coulter, Inc.	Opposable-element assay devices, kits, and methods employing them
US5874423A (en) *	1992-09-10	1999-02-23	Yissum Research Development Co. Of The Hebrew University Of Jerusalem	Digitalis-like compounds
AU679008B2 (en) *	1993-05-06	1997-06-19	Chiron Diagnostics Corporation	Mixed luminescent conjugate test assays
AU2635295A (en) *	1994-06-13	1996-01-05	Henry Ford Health System	A novel neuronal-neonatal gene: neuronatin
US5843673A (en) *	1994-10-25	1998-12-01	Curators Of The University Of Missouri	Method of screening for endometriosis
US6531277B2 (en)	1994-10-25	2003-03-11	The Curators Of The University Of Missouri	Endometriosis-specific secretory protein
US20030152909A1 (en) *	1994-11-16	2003-08-14	Mitrani Eduardo N.	In vitro micro-organs, and uses related thereto
US6331273B1 (en)	1995-04-25	2001-12-18	Discovery Partners International	Remotely programmable matrices with memories
US5751629A (en) *	1995-04-25	1998-05-12	Irori	Remotely programmable matrices with memories
US6416714B1 (en) *	1995-04-25	2002-07-09	Discovery Partners International, Inc.	Remotely programmable matrices with memories
US5874214A (en) *	1995-04-25	1999-02-23	Irori	Remotely programmable matrices with memories
US6017496A (en) *	1995-06-07	2000-01-25	Irori	Matrices with memories and uses thereof
US5741462A (en) *	1995-04-25	1998-04-21	Irori	Remotely programmable matrices with memories
US6329139B1 (en)	1995-04-25	2001-12-11	Discovery Partners International	Automated sorting system for matrices with memory
US5777093A (en) *	1995-05-16	1998-07-07	Ramot-University Authority For Applied Research & Industrial Development Ltd.	cDNAs associated with ataxia-telangiectasia
US5728807A (en) *	1995-05-16	1998-03-17	Ramot-University Authority For Applied Research And Industrial Development, Ltd.	Mutated proteins associated with ataxia-telangiectasia
US5858661A (en) *	1995-05-16	1999-01-12	Ramot-University Authority For Applied Research And Industrial Development	Ataxia-telangiectasia gene and its genomic organization
CA2228970A1 (fr) *	1995-08-18	1997-02-27	Donald W. Landry	Detection de composes organiques par regulation de reactions catalysees par des anticorps
US5840322A (en) *	1996-12-19	1998-11-24	Ramot-University Authority For Applied Research & Industrial Devel. Ltd.	Anti-oral-microbial adhesion fraction derived from vaccinium
DE19730497C2 (de) *	1997-07-16	2000-02-10	Heermann Klaus Hinrich	Verfahren zum Waschen, zur Separierung und Konzentrierung von Biomolekülen unter Verwendung eines Magnetstifts
US20030104973A1 (en) *	1997-08-21	2003-06-05	Quark Biotech, Inc.	Hypoxia-regulated genes
ATE293633T1 (de)	1997-08-21	2005-05-15	Quark Biotech Inc	Hypoxie-regulierte gene
US7973156B2 (en) *	1997-08-21	2011-07-05	Quark Pharmaceuticals Inc.	Hypoxia-regulated genes
US6284496B1 (en)	1997-10-03	2001-09-04	University Of South Florida	DNA vector for determining the presence of out-of-reading-frame mutations
EP1027453A4 (fr)	1997-10-17	2004-12-01	Univ South Florida	Procede de diagnostic et de surveillance des deficiences immunitaires cellulaires
US7687057B2 (en)	1998-01-09	2010-03-30	Yissum Research Development Company Of The Hebrew University Of Jerusalem	In vitro micro-organs, and uses related thereto
US20080206206A1 (en)	1998-05-07	2008-08-28	University Of South Florida	Bone marrow-derived neuronal cells
US6344443B1 (en)	1998-07-08	2002-02-05	University Of South Florida	Peptide antagonists of tumor necrosis factor alpha
AU4994899A (en)	1998-07-13	2000-02-01	University Of South Florida	Modulation of the phospholipase a2 pathway as a therapeutic
US6187563B1 (en)	1998-08-07	2001-02-13	Yale University	βIV-spectrin-polypeptides and nucleic acids encoding same
BR9914465A (pt) *	1998-09-29	2001-10-09	Gamida Cell Ltd	Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células
JP4523169B2 (ja)	1999-02-04	2010-08-11	プルリステムリミテッド	造血幹細胞および／または前駆細胞を維持および増加するための方法および装置
US6440682B1 (en) *	1999-05-28	2002-08-27	Detroit R&D Inc.	Detection of hypertension using immunoreactive metabolic products
US6787318B1 (en)	1999-06-01	2004-09-07	Roskamp Research Institute, Llc	Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
US7534605B2 (en)	1999-06-08	2009-05-19	Yissum Research Development Company Of The Hebrew University Of Jerusalem	CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US20060127366A1 (en) *	1999-06-25	2006-06-15	Mitrani Eduardo N	Method and device for inducing biological processes by micro-organs
CA2435411A1 (fr) *	1999-06-25	2001-01-04	Yissum Research Development Company Of The Hebrew University Of Jerusale M	Procede permettant d'induire une angiogenese au moyen de micro-organes
US6875582B1 (en)	1999-08-19	2005-04-05	Omniscience Pharmaceuticals, Inc.	Methods and targets of antibiotic resistance
US7101839B1 (en)	1999-08-30	2006-09-05	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Methods of and compositions for inhibiting the proliferation of mammalian cells
US7811981B2 (en) *	1999-08-30	2010-10-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Methods of and compositions for inhibiting the proliferation of mammalian cells
US6998232B1 (en)	1999-09-27	2006-02-14	Quark Biotech, Inc.	Methods of diagnosing bladder cancer
NZ519043A (en)	1999-11-19	2006-12-22	Yissum Res Dev Co	Nucleic acid comprising a gene derived from Aspergillus niger that encodes a polypeptide that has a beta-glucosidase catalytic activity
US6544506B2 (en) *	2000-01-05	2003-04-08	Yeda Research & Development Co. Ltd.	Veto cells effective in preventing graft rejection and devoid of graft versus host potential
AU2001225441A1 (en) *	2000-01-24	2001-07-31	Agricultural Research Organization The Volcani Center	Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
EP2316950A1 (fr)	2000-03-27	2011-05-04	Technion Research and Development Foundation, Ltd.	Complexes majeurs d'histocompatibilite monocatenaires de classe 1, constructions les codant et leurs methodes de production
US20040191260A1 (en)	2003-03-26	2004-09-30	Technion Research & Development Foundation Ltd.	Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
IL135884A (en) *	2000-04-30	2005-08-31	Yissum Res Dev Co	Method for measuring non-transferrin bound iron
HUP0300810A2 (hu)	2000-07-20	2003-08-28	M.G.V.S. Ltd.	Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
US20040037828A1 (en)	2002-07-09	2004-02-26	Bar-Ilan University	Methods and pharmaceutical compositions for healing wounds
US20030114410A1 (en) *	2000-08-08	2003-06-19	Technion Research And Development Foundation Ltd.	Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
DK1315519T3 (da)	2000-08-08	2011-04-11	Technion Res & Dev Foundation	Farmaceutiske sammensætninger og fremgangsmåder, der kan anvendes til behandling af cancer eller leverfibrose
EP1683874A3 (fr)	2000-08-29	2006-10-11	YEDA RESEARCH AND DEVELOPMENT Co. LTD.	Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
US7632522B2 (en) *	2000-09-28	2009-12-15	Nanocyte Inc.	Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US20070281037A9 (en) *	2000-09-28	2007-12-06	Nanocyte Inc.	Sterile preparations and compositions including stinging capsules and methods of producing and using same
WO2002026191A2 (fr) *	2000-09-28	2002-04-04	Nanocyte Inc.	Procedes, compositions et dispositifs utilisant des cellules/capsules urticantes pour administrer un agent therapeutique ou cosmetique dans un tissu
US8071740B2 (en)	2000-11-17	2011-12-06	Vascular Biogenics Ltd.	Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
PT2186530E (pt)	2000-11-17	2013-08-02	Vascular Biogenics Ltd	Promotores que apresentam uma especificidade das células endoteliais e os métodos de usar os mesmos
EP2425841A1 (fr)	2000-11-24	2012-03-07	Vascular Biogenics Ltd.	Procédés utilisant et compositions contenant des phospholipides oxydés définis pour la prévention et le traitement de l'athérosclérose
AU2002221013A1 (en) *	2000-11-30	2002-06-11	Yeda Research And Development Co..Ltd.	Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
WO2002044736A2 (fr)	2000-11-30	2002-06-06	Molecular Skincare Limited	Diagnostic et traitement de maladie
US20050202098A1 (en) *	2001-01-31	2005-09-15	Tolaren	Disease therapy using dying or dead cells
AU2002230061A1 (en) *	2001-01-31	2002-08-12	Tolaren	Induction of tolerance by apoptotic and/or necrotic cells
US20020117169A1 (en) *	2001-02-27	2002-08-29	Kurz Daniel R.	Cover and applicator for a portion of a mammalian body
US20030003454A1 (en)	2001-03-23	2003-01-02	Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science	Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
US6770622B2 (en)	2001-06-08	2004-08-03	Gary A. Jarvis	N-terminally truncated galectin-3 for use in treating cancer
US20050022269A1 (en) *	2001-07-19	2005-01-27	Joseph Hirschberg	Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
AU2002330724A1 (en)	2001-08-16	2003-03-10	Bar Ilan University	Diagnosis, prevention and treatment of cancer
US20040136972A1 (en)	2001-09-07	2004-07-15	Yeda Research And Development Co. Ltd.	Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
US7138144B2 (en) *	2001-09-07	2006-11-21	Nadir Askenasy	Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
KR100866117B1 (ko)	2001-10-19	2008-10-31	바스큘라 바이오제닉스 리미티드	혈관형성의 표적화 억제조절 및 항암 치료를 위한폴리뉴클레오타이드 작제물, 약학적 조성물 및 방법
AU2002358947A1 (en) *	2001-12-05	2003-06-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
US20050085432A1 (en) *	2001-12-26	2005-04-21	Aviva Lapidot	Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
IL152904A0 (en)	2002-01-24	2003-06-24	Gamida Cell Ltd	Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (fr) *	2002-01-25	2006-06-07	Gamida Cell Ltd	Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
US7781396B2 (en) *	2002-01-31	2010-08-24	Tel Aviv University Future Technology Development L.P.	Peptides directed for diagnosis and treatment of amyloid-associated disease
US20040052928A1 (en) *	2002-09-06	2004-03-18	Ehud Gazit	Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US6992176B2 (en) *	2002-02-13	2006-01-31	Technion Research & Development Foundation Ltd.	Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
CA2476625A1 (fr) *	2002-02-20	2003-08-28	Dyax Corp.	Ligands de liaison au complexe mhc-peptide
CA2479679A1 (fr) *	2002-03-18	2003-09-25	Gamida-Cell Ltd.	Procedes permettant d'induire la differenciation dans des cellules souches expansees ex vivo
WO2003079967A2 (fr) *	2002-03-26	2003-10-02	Nanocyte Inc.	Cellules urticantes exprimant un polynucleotide exogene qui code pour un agent therapeutique, diagnostic ou cosmetique, et procedes, compositions et dispositifs faisant intervenir l'utilisation de ces cellules urticantes ou de capsules derivees de celles-ci pour administrer l'agent therapeutique, diagnostic ou cosmetique a
US20040121442A1 (en) *	2002-05-05	2004-06-24	Ilan Chet	Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
US7404951B2 (en)	2002-08-01	2008-07-29	Yeda Research And Development Co. Ltd.	Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
US7267981B2 (en)	2002-10-07	2007-09-11	Technion Research & Development Foundation Ltd.	Human foreskin fibroblasts for culturing ES cells
WO2004034059A1 (fr) *	2002-10-11	2004-04-22	Sentina Biotechnology Incorporated	Methodes de detection du cancer du sein
WO2004037204A2 (fr) *	2002-10-25	2004-05-06	University Of South Florida	Methodes et composes de perturbation de la signalisation cd40r/cd40l dans le traitement de la maladie d'alzheimer
WO2004040252A2 (fr)	2002-10-30	2004-05-13	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Molecules et leurs procedes d'utilisation pour la mesure de fer non lie par la transferrine
US20050054097A1 (en) *	2002-11-17	2005-03-10	Tony Peled	EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
AU2003302701A1 (en) *	2002-11-29	2004-06-23	Technion Research And Development Foundation Ltd.	Method of dynamically culturing embryonic stem cells
US7491699B2 (en)	2002-12-09	2009-02-17	Ramot At Tel Aviv University Ltd.	Peptide nanostructures and methods of generating and using the same
PT2338896E (pt)	2002-12-12	2015-06-05	R B T Rakuto Bio Technologies Ltd	Utilização de lenhina-peroxidase para clarear a pele e os cabelos
ES2705683T3 (es)	2002-12-16	2019-03-26	Technion Res & Dev Foundation	Medio de cultivo de células madre pluripotentes
JP2006512079A (ja)	2003-01-02	2006-04-13	ラッパポート・ファミリー・インスティチュート・フォー・リサーチ・イン・ザ・メディカル・サイエンシズ	高血糖性患者の心疾患を予防するための抗酸化治療の有効性を予測する方法
DE602004020179D1 (de)	2003-01-07	2009-05-07	Univ Ramot	Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
WO2004078991A2 (fr)	2003-03-04	2004-09-16	Yeda Research And Development Co. Ltd.	Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
EP1601759A4 (fr) *	2003-03-07	2007-02-14	Gamida Cell Ltd	Extension de populations de cellules souches renouvelables au moyen de modulateurs de kinase pi 3
US8017113B2 (en)	2003-03-12	2011-09-13	Rappaport Family Institute For Research In The Medical Sciences	Compositions and methods for diagnosing and treating an inflammation
US7294701B2 (en) *	2003-04-02	2007-11-13	Technion Research & Development Foundation Ltd.	Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
EP2330132B1 (fr)	2003-04-04	2013-08-14	Yeda Research and Development Co. Ltd.	Anticorps contre MMP2 ou MMP9 et compositions pharmaceutiques contenant ces anticorps utiles pour inhiber l'activité de cettes métalloprotéines
JP4865540B2 (ja)	2003-04-08	2012-02-01	イエダリサーチアンドディベロップメントカンパニーリミテッド	化学誘引物質に対する増大された感受性を有する幹細胞およびそれを産生および使用する方法
FR2853551B1 (fr)	2003-04-09	2006-08-04	Lab Francais Du Fractionnement	Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
US7321065B2 (en) *	2003-04-18	2008-01-22	The Regents Of The University Of California	Thyronamine derivatives and analogs and methods of use thereof
AU2005234725B2 (en)	2003-05-22	2012-02-23	Evogene Ltd.	Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
WO2004104162A2 (fr)	2003-05-22	2004-12-02	Evogene Ltd.	Procedes d'augmentation de la tolerance du stress abiotique des plantes et plantes ainsi produites
US7554007B2 (en) *	2003-05-22	2009-06-30	Evogene Ltd.	Methods of increasing abiotic stress tolerance and/or biomass in plants
US20050020499A1 (en) *	2003-05-27	2005-01-27	Bar Ilan University	Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
US7498428B2 (en) *	2003-06-19	2009-03-03	Evogene Ltd.	Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US8129514B2 (en) *	2003-06-19	2012-03-06	Evogene Ltd.	Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
KR101215821B1 (ko)	2003-06-30	2012-12-28	텔 아비브 유니버시티 퓨쳐 테크놀로지 디벨롭먼트 엘.피.	아밀로이드 관련 질환을 진단 및 처치하기 위한 펩타이드, 그것에 대한 항체, 및 그 사용방법
RU2006107931A (ru) *	2003-08-14	2006-07-27	Дзе Байо Бэлэнс Корпорейшн (Us)	Бактериальные штаммы, включающие их композиции и их пробиотическое применение
US7625707B2 (en)	2003-10-02	2009-12-01	Ramot At Tel Aviv University Ltd.	Antibacterial agents and methods of identifying and utilizing same
IL158287A0 (en)	2003-10-07	2004-05-12	Yeda Res & Dev	Antibodies to nik, their preparation and use
PT1678209E (pt)	2003-10-07	2011-06-30	Yeda Res & Dev	Anticorpos para a nik, a sua preparação e a sua utilização
CN1918281A (zh) *	2003-10-23	2007-02-21	辉瑞产品公司	牙周病疫苗
ES2469670T3 (es)	2003-11-30	2014-06-18	Yeda Research And Development Co., Ltd.	Métodos y agentes para inmunomodulaci�n y métodos para identificar inmunomoduladores
WO2005059100A2 (fr) *	2003-12-12	2005-06-30	New York University	Procedes et compositions se rapportant a la cystatine c
US20100221233A1 (en) *	2003-12-15	2010-09-02	University Of South Florida	Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
EP2289567A3 (fr)	2003-12-22	2011-06-22	Regentis Biomaterials Ltd.	Matrice à base de protéines naturelles réticulées
DE602004028513D1 (de)	2003-12-23	2010-09-16	Mount Sinai Hospital Corp	Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
US8007847B2 (en) *	2004-01-13	2011-08-30	Eytan Biderman	Feeding formula appliance
US7423139B2 (en) *	2004-01-20	2008-09-09	Insight Biopharmaceuticals Ltd.	High level expression of recombinant human erythropoietin having a modified 5′-UTR
WO2005071058A2 (fr) *	2004-01-27	2005-08-04	Compugen Ltd.	Procedes et systemes pour l'annotation de sequences de biomolecules
EP1729793B1 (fr)	2004-03-02	2015-07-22	Acceleron Pharma Inc.	Inhibiteurs d'alk7 et de la myostatine pour le traitement de l'amyotrophie
US8352031B2 (en)	2004-03-10	2013-01-08	Impulse Dynamics Nv	Protein activity modification
WO2005115394A2 (fr) *	2004-04-20	2005-12-08	New York University School Of Medicine	Commutateur electrostatique prenyle et procedes d'utilisation
CN101948846A (zh) *	2004-06-14	2011-01-19	伊沃基因有限公司	参与植物纤维发育的多核苷酸和多肽和使用它们的方法
US8680062B2 (en) *	2004-07-06	2014-03-25	Deliversir Ltd.	System for delivering therapeutic agents into living cells and cells nuclei
US20090156471A1 (en) *	2004-07-15	2009-06-18	Ramot At Tel Aviv University Ltd.	Use of anti-amyloid agents for treating and typing pathogen infections
WO2006013552A2 (fr)	2004-08-02	2006-02-09	Ramot At Tel Aviv University Ltd.	Articles de nanostructures a base de peptides et leur procede de formation
WO2006027780A2 (fr)	2004-09-08	2006-03-16	Ramot At Tel Aviv University Ltd.	Nanostructures peptidiques contenant des peptides modifies par coiffage terminal, et procedes de generation et d'utilisation de celles-ci
WO2006030442A2 (fr) *	2004-09-16	2006-03-23	Gamida-Cell Ltd.	Methodes de culture ex vivo de cellules souches et de precurseur par co-culture avec des cellules mesenchymales
CA2582041C (fr) *	2004-09-29	2015-08-04	Levava Roiz	Rnase t2 humaine recombinee et utilisations associees
CA2582051C (fr)	2004-09-29	2015-08-11	Collplant Ltd.	Collagene de recombinaison produit dans une plante
US7781402B2 (en) *	2004-10-12	2010-08-24	Closed Loop Therapies Ltd.	Methods and implantable devices for treating supraventricular arrhythmias
US20060134680A1 (en) *	2004-12-22	2006-06-22	Alexander Kotlyar	Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
US8375327B2 (en) *	2005-01-16	2013-02-12	Zlango Ltd.	Iconic communication
JP2008529325A (ja) *	2005-01-16	2008-07-31	ズランゴーリミテッド	通信ネットワークシステムおよびそれを使用するための方法
US8019818B2 (en) *	2005-01-18	2011-09-13	Zlango Ltd.	Communications network system and methods for using same
DK1843850T3 (en)	2005-01-31	2015-12-07	Realbio Technologies Ltd	LATERAL FLOW STEERING CAPILLAR DEVICE
US8257742B2 (en)	2005-02-17	2012-09-04	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Bisphosphonates for treating endometriosis
US8216801B2 (en)	2005-02-25	2012-07-10	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center	Methods for treating inflammatory disorders
US7695927B2 (en) *	2005-03-18	2010-04-13	Detroit R & D	Detection of hypertension using glucuronidated metabolic products
WO2006109312A2 (fr) *	2005-04-15	2006-10-19	Vascular Biogenics Ltd.	Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire
US8834862B2 (en) *	2005-04-19	2014-09-16	Nanocyte Inc.	Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
EP1888034A2 (fr)	2005-05-26	2008-02-20	Yissum Research Development Company, of The Hebrew University of Jerusalem	Compositions et methodes d'utilisation desdites compositions dans l'administration d'agents dans un organe cible protege par une barriere sanguine
EP2465924A3 (fr)	2005-06-16	2013-01-02	Ramot at Tel-Aviv University Ltd.	Cellules isolées et populations les comportant pour le traitement des maladies du SNC
US20070225242A1 (en) *	2005-06-21	2007-09-27	The Board Of Trustees Of The Leland Stanford Junior University	Method and composition for treating and preventing tumor metastasis in vivo
WO2007007325A2 (fr)	2005-07-07	2007-01-18	Fulcrum Sp Ltd.	Polypeptides sp1, polypeptides sp1 modifies et leurs utilisations
US8067573B2 (en) *	2005-07-07	2011-11-29	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Nucleic acid agents for downregulating H19 and methods of using same
EP2441840B1 (fr)	2005-07-18	2017-09-06	Protalix Ltd.	Administration mucosale ou enterale de macromolecules biologiquement actives
EP1945257A4 (fr) *	2005-08-08	2009-05-06	Onconon Llc	Compositions d'anticorps, methodes de traitement de maladie neoplasique et methodes de regulation de la fertilite
EP1928479B1 (fr)	2005-08-24	2016-06-08	Yeda Research And Development Co., Ltd.	Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique
SG177946A1 (en)	2005-08-29	2012-02-28	Technion Res & Dev Foundation	Media for culturing stem cells
WO2007034487A1 (fr)	2005-09-22	2007-03-29	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Constructions d’acide nucléique, compositions pharmaceutiques et procédés utilisant ces dernières dans le cadre des traitements anticancéreux
WO2007043048A2 (fr) *	2005-10-11	2007-04-19	Ramot At Tel Aviv University Ltd.	Hydrogels auto-assembles et leurs procedes d'elaboration et d'utilisation
US20070087437A1 (en) *	2005-10-14	2007-04-19	Jifan Hu	Methods for rejuvenating cells in vitro and in vivo
EP2716654A1 (fr)	2005-10-24	2014-04-09	Evogene Ltd.	Polypeptides isolés, polynucléotides codant pour ces derniers, plantes transgéniques exprimant ces derniers et méthodes utilisant ces derniers
US7879212B2 (en) *	2005-11-03	2011-02-01	Ramot At Tel-Aviv University Ltd.	Peptide nanostructure-coated electrodes
US8846393B2 (en)	2005-11-29	2014-09-30	Gamida-Cell Ltd.	Methods of improving stem cell homing and engraftment
EP2390312A1 (fr)	2005-11-29	2011-11-30	Gamida Cell Ltd.	Méthodes d'amélioration de prise de greffe et de nostocytose de cellules souches
WO2007080559A2 (fr)	2006-01-16	2007-07-19	Zlango Ltd.	Communication iconique
US8476234B2 (en)	2006-02-03	2013-07-02	Prolor Biotech Inc.	Long-acting coagulation factors and methods of producing same
US20140113860A1 (en)	2006-02-03	2014-04-24	Prolor Biotech Ltd.	Long-acting polypeptides and methods of producing and administering same
US10221228B2 (en)	2006-02-03	2019-03-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US20150038413A1 (en)	2006-02-03	2015-02-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US9458444B2 (en)	2006-02-03	2016-10-04	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US8048849B2 (en)	2006-02-03	2011-11-01	Modigene, Inc.	Long-acting polypeptides and methods of producing same
US7553940B2 (en)	2006-02-03	2009-06-30	Modigene Inc	Long-acting EPO polypeptides and derivatives thereof and methods thereof
US9249407B2 (en)	2006-02-03	2016-02-02	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US10351615B2 (en)	2006-02-03	2019-07-16	Opko Biologics Ltd.	Methods of treatment with long-acting growth hormone
US8048848B2 (en)	2006-02-03	2011-11-01	Prolor Biotech Ltd.	Long-acting interferons and derivatives thereof and methods thereof
US8946155B2 (en)	2006-02-03	2015-02-03	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US8759292B2 (en)	2006-02-03	2014-06-24	Prolor Biotech, Llc	Long-acting coagulation factors and methods of producing same
US8450269B2 (en)	2006-02-03	2013-05-28	Prolor Biotech Ltd.	Long-acting growth hormone and methods of producing same
CN101416063A (zh)	2006-02-06	2009-04-22	拉帕波特家族医学科学研究所	用于诊断t1dm的方法和试剂盒
WO2007100580A2 (fr) *	2006-02-22	2007-09-07	The Texas A & M University System	Anticorps reconnaissant un antigène putatif hautement exprimé du sarm-c et procédés d'utilisation
JP5107943B2 (ja)	2006-03-06	2012-12-26	ゼティクテクノロジーズリミテッド	細胞の表現型を特定するための方法および組成物
KR101490449B1 (ko)	2006-03-23	2015-02-05	플루리스템 리미티드	세포 증식 방법 및 세포의 용도 및 치료를 위해 그 세포에 의해 제조되는 조절된 배지
WO2007110869A2 (fr)	2006-03-28	2007-10-04	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Procedes et kits pour determiner la predisposition a la resistance a la warfarine
CN101578297A (zh) *	2006-04-07	2009-11-11	美国政府健康及人类服务部	治疗肿瘤疾病的抗体组合物和方法
CN101448951B (zh) *	2006-05-19	2013-04-10	泰华制药工业有限公司	融合蛋白、其用途以及制备方法
US20070281883A1 (en) *	2006-06-05	2007-12-06	Hanna Rosenfeld	Development of follicle stimulating hormone agonists and antagonists in fish
WO2008010228A2 (fr)	2006-07-20	2008-01-24	Yeda Research And Development Co. Ltd.	Organismes photosynthétiques, compositions et procédés de génération desdits organismes
EP2064319B1 (fr)	2006-08-28	2017-02-22	Yeda Research and Development Co. Ltd.	Méthodes de production de cellules gliales et neuronales et leur utilisation pour le traitement de troubles médicaux du système nerveux central
US7888059B2 (en) *	2006-10-05	2011-02-15	Yeda Research And Development Co. Ltd.	Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
AU2007303821B9 (en)	2006-10-05	2013-06-20	Technion Research & Development Foundation Ltd.	Microtubes and methods of producing same
CA2703795A1 (fr)	2006-10-27	2008-05-02	Mount Sinai Hospital	Biomarqueurs endometriaux
US20080131954A1 (en) *	2006-11-30	2008-06-05	Canon U.S. Life Sciences, Inc.	Method of Separating Target DNA from Mixed DNA
EP2096909A4 (fr)	2006-12-20	2010-08-04	Evogene Ltd	Polynucleotides et polypeptides impliques dans le developpement de fibres vegetales et procedes d'utilisation
EP2111450A2 (fr) *	2007-01-16	2009-10-28	Yissum Research Development Company of the Hebrew University of Jerusalem	Acides nucléiques recombinés et procédés de silençage spécifique de h19
US20100196403A1 (en) *	2007-01-29	2010-08-05	Jacob Hochman	Antibody conjugates for circumventing multi-drug resistance
EP2117616A2 (fr)	2007-01-31	2009-11-18	Technion Research & Development Foundation Ltd.	Échafaudages électrofilés et leurs procédés de génération et d'utilisation
EP2125050B1 (fr)	2007-02-01	2014-07-30	Technion Research & Development Foundation Ltd.	Fibres et tissus d'albumine et leurs procédés de génération et d'utilisation
EP2134373A4 (fr)	2007-02-28	2014-04-02	Yeda Res & Dev	Sequences de ciblage du noyau
EP2144935A2 (fr)	2007-03-29	2010-01-20	Technion Research & Development Foundation Ltd.	Anticorps, procédés et kits de diagnostic et de traitement de mélanomes
WO2008120216A1 (fr)	2007-04-02	2008-10-09	Ramot At Tel Aviv University Ltd.	Procédés permettant de détecter des cellules cancéreuses et leur utilisation pour diagnostiquer et surveiller le traitement de la maladie
CN101854798B (zh) *	2007-04-09	2013-04-03	伊沃基因有限公司	用于增加植物的油含量、生长速率和/或产量的多核苷酸、多肽和方法
US9156865B2 (en)	2007-04-23	2015-10-13	Deliversir Ltd	System for delivering therapeutic agents into living cells and cells nuclei
US9556210B2 (en)	2007-04-23	2017-01-31	Sabag-Rfa Ltd.	System for delivering therapeutic agents into living cells and cells nuclei
PT2144633E (pt)	2007-04-23	2014-10-27	Deliversir Ltd	Um sistema para a administração de agentes terapêuticos em células vivas e núcleos de células
ES2564312T3 (es)	2007-05-01	2016-03-21	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Métodos y kits para detectar células fetales en la sangre materna
CN101820910B (zh)	2007-05-03	2014-08-06	新加坡科技研究局	结合细胞内prl-1多肽或prl-3多肽的抗体
SG187447A1 (en)	2007-05-07	2013-02-28	Protalix Ltd	Large scale disposable bioreactor
WO2008141318A1 (fr) *	2007-05-14	2008-11-20	Dr. Susan Love Research Foundation	Dispositif de détermination du risque de développement du cancer du sein et procédé pour celui-ci
WO2009007980A1 (fr)	2007-07-11	2009-01-15	Yeda Research And Development Co. Ltd.	Systèmes de produits de construction d'acide nucléique pouvant diagnostiquer ou traiter un état cellulaire
IL184627A0 (en)	2007-07-15	2008-12-29	Technion Res & Dev Foundation	Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
WO2009010968A2 (fr)	2007-07-15	2009-01-22	Yitzchak Hillman	Traitement de maladie par des peptides antimicrobien ou leurs inhibiteurs
BR122020022203B1 (pt)	2007-07-24	2021-04-20	Evogene Ltd	método de aumento da taxa de crescimento de uma planta
EP2543389A3 (fr)	2007-08-02	2013-04-24	Gilead Biologics, Inc.	Procédés et compositions de traitement et de diagnostic de fibrose, d'invasion tumorale, d'angiogenèse et de métastase
WO2009022328A2 (fr)	2007-08-15	2009-02-19	Yeda Research And Development Co. Ltd.	Régulateurs de la mmp-9 et leurs utilisations
AU2008299318A1 (en)	2007-09-12	2009-03-19	The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center	Methods of treating tumors in immune-privileged sites
JP2010539228A (ja)	2007-09-19	2010-12-16	プルリステムリミテッド	脂肪組織または胎盤組織に由来する接着性細胞および治療におけるその使用
US8088735B2 (en)	2007-10-19	2012-01-03	Rappaport Family Institute For Research In The Medical Sciences	Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
AU2008331099B2 (en)	2007-11-26	2013-10-24	Collplant Ltd.	Compositions comprising fibrous polypeptides and polysaccharides
WO2009083958A2 (fr)	2007-12-27	2009-07-09	Evogene Ltd.	Peptides isolés, polynucléotides utiles pour modifier l'efficacité d'utilisation de l'eau, l'efficacité d'utilisation d'engrais, la tolérance aux stress biotiques/abiotiques, le rendement et la biomasse dans des plantes
US20110052501A1 (en) *	2008-01-31	2011-03-03	Liat Dassa	Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
CA2618163A1 (fr)	2008-02-07	2009-08-07	K. W. Michael Siu	Biomarqueurs de cancer de la tete et du cou
WO2009104175A2 (fr)	2008-02-21	2009-08-27	Technion Research & Development Foundation Ltd.	Utilisation de microtubes électrofilés pour l'administration de médicaments
WO2009125394A1 (fr) *	2008-04-09	2009-10-15	Technion Research & Development Foundation Ltd.	Anticorps anti-immunodéficience humaine et leurs utilisations
WO2009125381A1 (fr) *	2008-04-10	2009-10-15	Objet Geometries Ltd.	Système et procédé pour l’impression de modèles en trois dimensions
CN102056619A (zh)	2008-04-18	2011-05-11	科尔普兰特有限公司	产生和使用原胶原的方法
WO2009130695A2 (fr)	2008-04-21	2009-10-29	Danziger Innovation Ltd.	Vecteurs d'expression de virus végétaux et leur utilisation pour générer des variations génotypiques dans des génomes de plantes
BRPI0910622A2 (pt)	2008-04-25	2020-03-10	Dyax Corp.	ANTICORPOS CONTRA FcRn E USOS DOS MESMOS
SG176464A1 (en)	2008-05-09	2011-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
BRPI0908666B1 (pt) *	2008-05-22	2021-06-15	Evogene Ltd	Método de aumento do teor do óleo, do rendimento de sementes, da taxa de crescimento e/ou da biomassa de uma planta quando comparada a uma planta nativa, e, construção de ácido nucleico isolado
CN102123717A (zh)	2008-05-27	2011-07-13	普拉里斯坦有限公司	治疗炎性结肠疾病的方法
ES2729557T3 (es)	2008-05-28	2019-11-04	Univ Ramot	Células madre mesenquimatosas para el tratamiento de enfermedades del SNC
EP2304439A4 (fr)	2008-05-29	2012-07-04	Nuclea Biotechnologies Llc	Anticorps anti-phospho-akt
WO2010007613A1 (fr)	2008-06-29	2010-01-21	Realbio Technologies Ltd.	Dispositif de transfert de liquide particulièrement utile comme dispositif de capture dans un processus de dosage biologique
JP5583667B2 (ja)	2008-08-08	2014-09-03	ジェニスフィア・エルエルシー	長時間作用型ｄｎａデンドリマーおよびその方法
GB2474807A (en)	2008-08-08	2011-04-27	Agency Science Tech & Res	Vhz for diagnosis and treatment of cancers
BR122021014172B1 (pt) *	2008-08-18	2022-09-06	Evogene Ltd	Método para aumentar a eficiência de uso do nitrogênio, eficiência de uso de fertilizantes, produção, taxa de crescimento, vigor, biomassa e/ou tolerância ao estresse de falta de nitrogênio de uma planta
EP2334783B1 (fr)	2008-09-02	2016-06-22	Pluristem Ltd.	Cellules adhérentes provenant d'un tissu placentaire et leur utilisation en thérapie
US8367392B2 (en) *	2008-09-05	2013-02-05	Transalgae Ltd.	Genetic transformation of algal and cyanobacteria cells by microporation
EP2326340A4 (fr)	2008-09-11	2013-01-23	Univ Ben Gurion	Compositions et procédés destinés à traiter une infection par s. pneumoniae
CN102186970A (zh)	2008-09-12	2011-09-14	克里奥普拉斯低温生物有限公司	缺血性组织的细胞疗法
AU2009295575B2 (en)	2008-09-24	2015-11-05	Tel Hashomer Medical Research, Infrastructure And Services Ltd.	Peptides and compositions for prevention of cell adhesion and methods of using same
CA2736729A1 (fr)	2008-09-29	2010-04-01	Ben Gurion University Of The Negev Research And Development Authority	Beta-peptides amyloides et procedes d'utilisation associes
US8921658B2 (en) *	2008-10-30	2014-12-30	Evogene Ltd.	Isolated polynucleotides encoding a MAP65 polypeptide and methods of using same for increasing plant yield
US20110229892A1 (en)	2008-11-17	2011-09-22	Yehuda G Assaraf	Method for predicting a patient's responsiveness to anti-folate therapy
WO2010058396A1 (fr)	2008-11-19	2010-05-27	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
WO2010061383A1 (fr)	2008-11-26	2010-06-03	Biodalia Microbiological Technologies Ltd.	Procédé permettant d’enrichir in-situ des aliments avec des fructanes
WO2010064231A1 (fr)	2008-12-02	2010-06-10	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
US20120014927A1 (en)	2008-12-03	2012-01-19	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Methods and kits for determining predisposition to cancer
EP2373301B1 (fr)	2008-12-05	2013-11-06	Yeda Research and Development Co. Ltd.	Procédés de diagnostic des maladies des motoneurones
WO2010071610A1 (fr)	2008-12-19	2010-06-24	Agency For Science, Technology And Research (A*Star)	Marqueurs biologiques de chikungunya sévère
AR074925A1 (es)	2008-12-29	2011-02-23	Evogene Ltd	Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para modular la tolerancia al estres abiotico, biomasa y/o rendimiento en plantas que los expresan
SG10201504379VA (en)	2008-12-29	2015-07-30	Tel Hashomer Medical Res Infrastructure & Services Ltd	Peptides and compositions for prevention of cell adhesion and methods of using same
EP2808402A3 (fr)	2008-12-29	2015-03-25	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Méthodes de prédiction de la réponse au traitement par interférons
WO2010076794A1 (fr)	2008-12-31	2010-07-08	Technion Research & Development Foundation Ltd.	Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
US9107935B2 (en) *	2009-01-06	2015-08-18	Gilead Biologics, Inc.	Chemotherapeutic methods and compositions
IL196820A0 (en)	2009-02-01	2009-11-18	Yissum Res Dev Co	Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
EP2391377A2 (fr)	2009-02-02	2011-12-07	Ramot at Tel-Aviv University Ltd.	Peptides, compositions pharmaceutiques en contenant et leurs utilisations
WO2010089707A1 (fr)	2009-02-04	2010-08-12	Yeda Research And Development Co. Ltd.	Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
EP2401362B1 (fr)	2009-02-26	2017-04-12	Tel HaShomer Medical Research Infrastructure and Services Ltd.	Populations isolées de cellules souches rénales et leurs procédés d'isolement et d'utilisation
MX342016B (es)	2009-03-02	2016-09-09	Evogene Ltd	Polinucleotidos y polipeptidos aislados, y metodos para usarlos para incrementar el rendimiento de una planta y/o caracteristicas agricolas.
EP2406279B1 (fr)	2009-03-09	2016-01-27	Ramot at Tel-Aviv University Ltd.	Compositions pour la prévention et le traitement de maladies neurodégénératives
WO2010103517A1 (fr)	2009-03-12	2010-09-16	Rappaport Family Institute For Research In The Medical Sciences	Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
EP2414542B1 (fr)	2009-03-30	2017-08-30	Tel HaShomer Medical Research Infrastructure and Services Ltd.	Méthodes pour prévoir l'évolution clinique de la sclérose en plaque et la traiter
CA2759201A1 (fr)	2009-04-01	2010-10-07	The Medical Research, Infrastructure, And Health Services Fund Of The Te L Aviv Medical Center	Procede de regulation de la proliferation et de la differenciation des keratinocytes
WO2010116375A1 (fr)	2009-04-08	2010-10-14	Yeda Research And Development Co. Ltd.	Peptides isolés pour réguler l'apoptose
HRP20151099T8 (en)	2009-04-30	2016-01-29	Tel Hashomer Medical Research	Anti ceacam1 antibodies and methods of using same
WO2010134073A1 (fr)	2009-05-19	2010-11-25	Zetiq Technologies Ltd.	Kits et procédés pour coloration différentielle de cellules et/ou tissus cancéreux du col de l'utérus
WO2010137013A1 (fr)	2009-05-27	2010-12-02	Ramot At Tel Aviv University Ltd.	Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
WO2010137017A2 (fr)	2009-05-27	2010-12-02	Yeda Research And Development Co. Ltd.	Inhibiteurs des protéasomes et leurs utilisations
US20120078163A1 (en)	2009-05-27	2012-03-29	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method of generating connective tissue
WO2010137020A1 (fr)	2009-05-28	2010-12-02	Yeda Research And Development Co. Ltd.	Méthodes de traitement d'inflammation
US9096865B2 (en)	2009-06-10	2015-08-04	Evogene Ltd.	Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
US20120129183A1 (en)	2009-06-24	2012-05-24	Rappaport Family Institute For Research In The Medical Sciences	Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
US12203113B2 (en)	2009-07-09	2025-01-21	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US9663778B2 (en)	2009-07-09	2017-05-30	OPKO Biologies Ltd.	Long-acting coagulation factors and methods of producing same
WO2011004379A1 (fr)	2009-07-10	2011-01-13	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Compositions et méthodes de traitement du cancer
ES2753986T3 (es)	2009-07-21	2020-04-15	Tel Hashomer Medical Res Infrastructure & Services Ltd	Un método de diagnóstico de cáncer
GB0913442D0 (en)	2009-07-31	2009-09-16	Univ Ramot	Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
EP2467470A2 (fr)	2009-08-17	2012-06-27	Technion Research & Development Foundation Ltd.	Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
RU2015124151A (ru) *	2009-08-21	2015-12-27	Джилид Байолоджикс, Инк.	Способы и композиции для лечения фиброзных заболеваний легких
JP2013502437A (ja) *	2009-08-21	2013-01-24	ギリアドバイオロジクス，インク．	治療方法及び組成物
RU2012110585A (ru) *	2009-08-21	2013-09-27	Джилид Байолоджикс, Инк.	Каталичические домены лизилоксидазы и loxl2
WO2011022670A1 (fr) *	2009-08-21	2011-02-24	Arresto Biosciences, Inc	Essais de criblage in vivo
CN102481311A (zh)	2009-08-21	2012-05-30	比欧洛吉科斯公司	经由植物转录的分子预防和治疗有益昆虫的疾病
CN102713601A (zh) *	2009-08-21	2012-10-03	吉联亚生物科技有限公司	体外筛选试验
CN102596179A (zh)	2009-08-27	2012-07-18	工业研究与发展基金会有限公司	脂质体组合物及其用途
EP2475381A2 (fr)	2009-09-08	2012-07-18	Yeda Research and Development Co. Ltd.	Procédés pour la mobilisation de précurseur hématopoïétique
WO2011030336A1 (fr)	2009-09-08	2011-03-17	Ramot At Tel-Aviv University Ltd.	Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
WO2011030329A1 (fr)	2009-09-10	2011-03-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Méthode de traitement de tumeurs
WO2011033506A2 (fr)	2009-09-17	2011-03-24	Yeda Research And Development Co. Ltd.	Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
BR112012006005A2 (pt)	2009-09-17	2017-09-19	Univ Ramot	"peptídeos no tratamento de transtorno associados ao estresse oxidativo"
US8735124B2 (en)	2009-09-17	2014-05-27	Yeda Research And Development Co. Ltd.	Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
US20110081706A1 (en) *	2009-10-02	2011-04-07	TransAlgae Ltd	Method and system for efficient harvesting of microalgae and cyanobacteria
MX353880B (es)	2009-10-14	2018-01-31	Yissum Research Development Company Of The Hebrew Univ Of Jerusalem Ltd Star	Composiciones para controlar ácaros varroa en abejas.
US8962584B2 (en)	2009-10-14	2015-02-24	Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd.	Compositions for controlling Varroa mites in bees
EP2488209B1 (fr)	2009-10-16	2016-09-28	Rutgers, the State University of New Jersey	Procédé de traitement d'une lésion chronique du tissu nerveux à l'aide d'une stratégie de thérapie de cellules
US9476060B2 (en)	2009-10-21	2016-10-25	Danziger Innovations Ltd.	Generating genotypic variations in plant genomes by gamete infection
IL201999A (en)	2009-11-08	2017-10-31	Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel	A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
WO2011058557A1 (fr)	2009-11-12	2011-05-19	Ramot At Tel-Aviv University Ltd.	Compositions contenant du pedf et leurs utilisations dans le traitement et la prévention de syndromes liés aux ovaires
ES2932664T3 (es)	2009-11-12	2023-01-23	Technion Res & Dev Foundation	Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en estado no diferenciado
US20110143378A1 (en) *	2009-11-12	2011-06-16	CyVek LLC.	Microfluidic method and apparatus for high performance biological assays
WO2011058555A1 (fr)	2009-11-12	2011-05-19	Yeda Research And Development Co. Ltd.	Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
WO2011061736A1 (fr)	2009-11-17	2011-05-26	Protalix Ltd.	Alpha galactosidase alcaline pour le traitement de la maladie de fabry
US9855735B2 (en)	2009-11-23	2018-01-02	Cyvek, Inc.	Portable microfluidic assay devices and methods of manufacture and use
WO2013134740A1 (fr)	2012-03-08	2013-09-12	Cyvek, Inc.	Procédés et systèmes de surveillance et d'analyse épi-fluorescents destinés à des essais microfluidiques
US9651568B2 (en)	2009-11-23	2017-05-16	Cyvek, Inc.	Methods and systems for epi-fluorescent monitoring and scanning for microfluidic assays
US9229001B2 (en)	2009-11-23	2016-01-05	Cyvek, Inc.	Method and apparatus for performing assays
US9700889B2 (en)	2009-11-23	2017-07-11	Cyvek, Inc.	Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results
US9759718B2 (en)	2009-11-23	2017-09-12	Cyvek, Inc.	PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use
US9500645B2 (en)	2009-11-23	2016-11-22	Cyvek, Inc.	Micro-tube particles for microfluidic assays and methods of manufacture
US10065403B2 (en)	2009-11-23	2018-09-04	Cyvek, Inc.	Microfluidic assay assemblies and methods of manufacture
US20120273993A1 (en)	2009-11-24	2012-11-01	Collplant Ltd.	Method of generating collagen fibers
AU2010322808B9 (en)	2009-11-30	2014-08-07	Pluri Biotech Ltd	Adherent cells from placenta and use of same in disease treatment
US9562235B2 (en)	2009-12-06	2017-02-07	A.B. Seeds Ltd.	MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
EP2510098B1 (fr)	2009-12-09	2015-02-11	Quark Pharmaceuticals, Inc.	Méthodes et compositions utilisées pour le traitement de maladies, d'affections ou de lésions du snc
MX381519B (es)	2009-12-28	2025-03-12	Evogene Ltd	Polinucleótidos y polipéptidos aislados y métodos para utilizarlos para aumentar el rendimiento de la planta, biomasa, tasa de crecimiento, vigor, contenido de aceite, tolerancia al estrés abiótico y eficacia en el uso de nitrógeno.
CA2785627C (fr)	2009-12-29	2020-02-18	Gamida-Cell Ltd.	Methodes d'amplification de la proliferation et de l'activite des cellules tueuses naturelles
DK2521776T3 (en)	2010-01-05	2017-02-13	Vascular Biogenics Ltd	METHODS FOR USING A SPECIFIC ANTI-ANGIOGENT ADENOVIRAL AGENT
JP6009357B2 (ja)	2010-01-12	2016-10-19	バスキュラーバイオジェニックスリミテッド	アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物
US8697078B2 (en)	2010-01-27	2014-04-15	Yeda Research And Development Co. Ltd.	Antibodies that inhibit metalloproteins
RU2549684C2 (ru)	2010-02-04	2015-04-27	Джилид Байолоджикс, Инк.	Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
US9410131B2 (en)	2010-02-11	2016-08-09	Yeda Research And Development Co. Ltd.	Enzymatic systems for carbon fixation and methods of generating same
WO2011104708A2 (fr)	2010-02-24	2011-09-01	Ben Gurion University Of The Negev Research And Development Authority	Méthodes d'inhibition de la nécrose
WO2011107939A1 (fr)	2010-03-01	2011-09-09	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
WO2011107994A1 (fr)	2010-03-04	2011-09-09	Yeda Research And Development Co. Ltd.	Procédés de mesure de la stabilité d'une protéine
BR112012022570A2 (pt)	2010-03-08	2015-10-06	Monsato Technology Llc	moléculas de polinucleotídeo para regulação de gene em plantas.
US9267142B2 (en)	2010-03-08	2016-02-23	Yeda Research And Development Co. Ltd.	Recombinant protein production in heterologous systems
US20120329089A1 (en)	2010-03-11	2012-12-27	Jacob Edrei	Methods of generating hydrogen
WO2011125015A2 (fr)	2010-04-05	2011-10-13	Bar-Ilan University	Polypeptides formant des pores pouvant être activés par une protéase
EP2557913B1 (fr)	2010-04-12	2016-08-03	Ben Gurion University Of The Negev Research And Development Authority	Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
WO2011128897A1 (fr)	2010-04-12	2011-10-20	Technion Research & Development Foundation Ltd.	Population de cellules progénitrices pancréatiques et leurs méthodes d'isolement et d'utilisation
CA2792826A1 (fr)	2010-04-18	2011-10-27	Yeda Research And Development Co. Ltd.	Molecules et methodes d'utilisation de celles-ci pour le traitement des maladies associees aux ligands erbb/erbb
MX344729B (es)	2010-04-28	2017-01-05	Evogene Ltd	Polinucleótidos y polipéptidos aislados, y métodos para utilizarlos para mejorar el rendimiento de la planta y/o las características agrícolas.
WO2011138778A2 (fr)	2010-05-04	2011-11-10	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Procédés permettant d'identifier des inhibiteurs de polypeptides d'intérêt
US9352000B2 (en)	2010-05-05	2016-05-31	Rappaport Family Institute For Research In The Medical Sciences	Use of CCL1 in therapy
IL208820A0 (en)	2010-10-19	2011-01-31	Rachel Teitelbaum	Biologic female contraceptives
US20130059325A1 (en)	2010-05-13	2013-03-07	Tel HaShomer Medical Research Infratructure and Services Ltd.	Isolated populations of adult renal cells and methods of isolating and using same
CN103037891A (zh)	2010-06-03	2013-04-10	雷蒙特亚特特拉维夫大学有限公司	治疗糖尿病的方法和能够治疗糖尿病的组合物
US20130316351A1 (en)	2010-06-07	2013-11-28	Osnat Ashur-Fabian	Methods and kits for diagnosing conditions related to hypoxia
WO2011158243A2 (fr)	2010-06-16	2011-12-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Procédé de diagnostic et de traitement du cancer
CN103154022A (zh)	2010-06-16	2013-06-12	富途锐基尼以色列有限公司	抗害虫植物
WO2012007945A2 (fr)	2010-07-12	2012-01-19	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center	Polynucléotides isolés et procédés et plantes les utilisant pour la régulation de l'acidité des plantes
WO2012007950A2 (fr)	2010-07-15	2012-01-19	Technion Research & Development Foundation Ltd.	Entités de haute affinité isolées présentant une spécificité de type récepteur des lymphocytes t pour les complexes natifs du mhc de classe ii et les peptides auto-antigéniques associés au diabète
EP2593554A2 (fr)	2010-07-15	2013-05-22	Technion Research And Development Foundation Ltd.	Construction d'acide nucléique destinée à accroître la tolérance au stress abiotique dans des végétaux
JP2013538555A (ja)	2010-07-15	2013-10-17	テクニオンリサーチアンドディベロップメントファウンデーションリミテッド	Ｍｈｃクラスｉｉとグルタミン酸デカルボキシラーゼ（ｇａｄ）自己抗原性ペプチドとの天然型複合体に対するｔ細胞受容体様特異性を有する単離された高親和性実体
WO2012011113A2 (fr)	2010-07-22	2012-01-26	Shai Yarkoni	Cellules immunitaires régulatrices possédant un effet de destruction cellulaire ciblé accru
US20130130311A1 (en)	2010-07-27	2013-05-23	Yeda Research And Development Co., Ltd.	Methods and systems for assessing clonality of cell cultures
US20130130387A1 (en)	2010-07-27	2013-05-23	Technion Research & Development Foundation Limited	Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
US9144585B2 (en)	2010-07-27	2015-09-29	Technion Research & Development Foundation Limited	Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
EP2600885A2 (fr)	2010-08-04	2013-06-12	Ramot at Tel Aviv University, Ltd.	Procédés de traitement de maladies auto-immunes du système nerveux central (snc) et de maladies neurodégénératives
US9040464B2 (en)	2010-08-16	2015-05-26	Mount Sinai Hosptial	Markers of the male urogenital tract
US9394523B2 (en)	2010-08-22	2016-07-19	Ramot At Tel-Aviv University Ltd.	Induced pluripotent stem cells derived from human pancreatic beta cells
WO2012025925A1 (fr)	2010-08-24	2012-03-01	Rappaport Family Institute For Research In The Medical Sciences	Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
US10457954B2 (en)	2010-08-30	2019-10-29	Evogene Ltd.	Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
DK2614141T3 (da)	2010-09-07	2019-09-09	Technion Res & Dev Foundation	Hidtil ukendte fremgangsmåder og dyrkningsmedier til dyrkning af pluripotente stamceller
WO2012032520A1 (fr)	2010-09-07	2012-03-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
WO2012032519A2 (fr)	2010-09-07	2012-03-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Méthodes de diagnostic de la maladie de parkinson
WO2012032510A1 (fr)	2010-09-07	2012-03-15	Yeda Research And Development Co. Ltd.	Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
ES2589678T3 (es)	2010-09-08	2016-11-15	Yeda Research And Development Co. Ltd.	Uso de linfocitos T de memoria central anti-terceros para el tratamiento anti-leucemia/linfoma
MX2013002667A (es)	2010-09-08	2013-08-01	Yeda Res & Dev	Una combinacion de farmacos inmunosupresores para un injerto estable y a largo plazo.
EP2616539A1 (fr)	2010-09-15	2013-07-24	Ramot at Tel-Aviv University Ltd.	Procédés d'expansion et de redifférenciation de cellules bêta des îlots
US20130210901A1 (en)	2010-09-20	2013-08-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Method of treating neurodegenerative diseases
EP2627766B1 (fr)	2010-10-17	2016-05-25	Yeda Research and Development Co. Ltd.	Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
WO2012052878A1 (fr)	2010-10-19	2012-04-26	Vascular Biogenics Ltd.	Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
US20130216603A1 (en)	2010-10-27	2013-08-22	Nanocyte (Israel) Ltd.	Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
WO2012056455A1 (fr)	2010-10-28	2012-05-03	Yeda Research And Development Co. Ltd.	Procédés de génération d'anticorps anti-métalloenzymes
UY33705A (es)	2010-11-03	2012-04-30	Yissum Res Dev Co	Plantas transgenicas con rendimientos de sacarificacion mejorados y metodos para generarlas
EP2635105B1 (fr)	2010-11-04	2017-12-20	Ben-Gurion University of The Negev Research and Development Authority	Acyl-coa: gène de type diacylglycérol acyltransférase 1 (ptdgat1) et utilisations de celui-ci
MX2013005413A (es)	2010-11-15	2014-02-27	Univ Ramot	Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides.
US10117895B2 (en)	2010-11-17	2018-11-06	Ben-Gurion University Of The Negev Research And Development Authority	T-cell therapy to neurodegenerative diseases
JP6139410B2 (ja)	2010-12-02	2017-05-31	テクニオンリサーチアンドディベロップメントファウンデーションリミテッド	角膜細胞の作製方法および該角膜細胞を含む細胞集団
EP2463382A1 (fr)	2010-12-07	2012-06-13	Enterologics, Inc.	Procédé d'identification de E. Coli M-17
WO2012081029A1 (fr)	2010-12-15	2012-06-21	Kadimastem Ltd.	Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
BR112013015830B8 (pt)	2010-12-22	2022-07-19	Evogene Ltd	Método de aumento de produção, biomassa, taxa de crescimento, vigor, tolerância ao estresse abiótico, e/ou eficiência no uso de nitrogênio de uma planta, e, construção de ácido nucleico
CN103533947A (zh)	2010-12-28	2014-01-22	卡梅迪斯有限公司	用于治疗和预防感染的植物提取物
SMT202000201T1 (it)	2011-01-20	2020-05-08	Protalix Ltd	Composizioni di alfa-galattosidasi
US20130316358A1 (en)	2011-01-31	2013-11-28	Yeda Research And Development Co. Ltd.	Methods of diagnosing disease using overlap extension pcr
WO2012114339A1 (fr)	2011-02-23	2012-08-30	Rappaport Family Institute For Research In The Medical Sciences	Molécules de haute affinité capables de se lier à un récepteur plexine de type a et leurs utilisations
WO2012117406A2 (fr)	2011-03-02	2012-09-07	Futuragene Israel Ltd.	Plantes transgéniques résistantes aux bactéries
US9365828B2 (en)	2011-03-03	2016-06-14	Ramot At Tel-Aviv University Ltd.	Genetically modified muscle cells which express neurotrophic factors
CN109797138A (zh)	2011-03-06	2019-05-24	默克雪兰诺有限公司	低岩藻糖细胞系及其应用
WO2012120518A1 (fr)	2011-03-08	2012-09-13	Ramot At Tel-Aviv University Ltd.	Compositions et méthodes de diagnostic et de traitement de phénylcétonurie (pcu)
EP2685976B1 (fr)	2011-03-17	2017-12-27	Tel HaShomer Medical Research Infrastructure and Services Ltd.	Analogues de quinolone pour le traitement de maladies auto-immunes
CN103429619B (zh)	2011-03-17	2017-07-28	雷蒙特亚特特拉维夫大学有限公司	双特异性和单特异性、不对称抗体和其制备方法
CN103649759B (zh)	2011-03-22	2016-08-31	西维克公司	微流体装置以及制造方法和用途
KR101903339B1 (ko)	2011-03-22	2018-10-01	플루리스템 리미티드	방사선 또는 화학적 손상을 치료하는 방법
JP5960793B2 (ja)	2011-03-24	2016-08-02	ニューリムファーマシューティカルズ（１９９１）リミテッド	神経保護ペプチド
WO2012131680A2 (fr)	2011-03-28	2012-10-04	Yeda Research And Development Co. Ltd.	Compositions et procédés pour le traitement de l'inflammation
WO2012137202A1 (fr)	2011-04-05	2012-10-11	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
US8728758B2 (en)	2011-04-06	2014-05-20	Ramot At Tel-Aviv University Ltd.	Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
WO2012142164A1 (fr)	2011-04-12	2012-10-18	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Anticorps monoclonaux humains qui se lient aux facteurs de croissance insulinomimétique (igf) de type i et ii
WO2012140519A2 (fr)	2011-04-15	2012-10-18	Pluristem Ltd.	Procédés et systèmes de récolte de cellules
AU2012251353B2 (en)	2011-05-03	2016-10-27	Evogene Ltd.	Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
US9192670B2 (en)	2011-05-04	2015-11-24	Ramot At Tel-Aviv University Ltd.	Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
WO2012153333A1 (fr)	2011-05-09	2012-11-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
WO2012153336A2 (fr)	2011-05-12	2012-11-15	Rakuto Bio Technologies Ltd.	Procédés et dispositifs pour éclaircir la carnation de la peau
WO2012156976A1 (fr)	2011-05-16	2012-11-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
WO2012160526A2 (fr)	2011-05-23	2012-11-29	Ofir Menashe	Formulations à base de particules contenant des micro-organismes et leurs utilisations
EP2715350B1 (fr)	2011-05-23	2017-09-27	Yeda Research and Development Co. Ltd.	Utilisation de la phosphorylation d'akt en tant que biomarqueur pour le pronostic et le traitement de maladies neurodégénératives
EP3527581A3 (fr)	2011-05-31	2019-11-27	Hutchison Biofilm Medical Solutions Limited	Dispersion et détachement d'agrégats cellulaires
WO2012164565A1 (fr)	2011-06-01	2012-12-06	Yeda Research And Development Co. Ltd.	Compositions et procédés pour la régulation à la baisse de gènes procaryotes
US10166295B2 (en)	2011-06-02	2019-01-01	Opko Biologics Ltd.	Pegylated OXM variants
EP2714084B1 (fr)	2011-06-02	2019-05-22	Dyax Corp.	PROTÉINES LIANT LE RÉCEPTEUR DE Fc
EP2720720B1 (fr)	2011-06-14	2018-02-28	Yeda Research and Development Co. Ltd.	Plurithérapie destinée à empêcher la formation de dcis et l'évolution en un cancer du sein
WO2012176203A1 (fr)	2011-06-23	2012-12-27	Kaiima Bio Agritech Ltd.	Blé commun, plantes ou parties de celles-ci ayant un génome partiellement ou complètement multiplié, hybrides et produits de ceux-ci, et procédés de génération et d'utilisation
MX2014000791A (es)	2011-07-20	2014-10-17	Kaiima Bio Agritech Ltd	Plantas de maiz que tienen un genoma parcial o completamente multiplicado y sus usos.
EP2550982A1 (fr)	2011-07-27	2013-01-30	Technion Research & Development Foundation Ltd.	Dispositifs pour applications chirurgicales
CN104039960B (zh)	2011-08-04	2017-05-10	耶达研究及发展有限公司	用于治疗和诊断与五羟色胺‑、肾上腺素‑、去甲肾上腺素‑、谷氨酸‑和促肾上腺皮质素释放激素相关的病症的微rna和包含微rna的组合物
WO2013021389A2 (fr)	2011-08-09	2013-02-14	Yeda Research And Development Co.Ltd.	Régulation à la baisse de mir-7 pour favoriser la différenciation des cellules bêta et la production d'insuline
US20140212568A1 (en)	2011-08-14	2014-07-31	Kaiimam Bio Agritech Ltd.	Durum wheat plants having a partially or fully multiplied genome and uses thereof
EP2753367A4 (fr)	2011-09-07	2015-10-14	Yeda Res & Dev	Signature olfactive et mélange odorant la contenant
EP2753716B1 (fr)	2011-09-08	2017-11-01	Yeda Research and Development Co. Ltd.	Nouveaux biomarqueurs de risque pour le cancer du poumon
KR102073901B1 (ko)	2011-09-08	2020-02-05	예다 리서치 앤드 디벨럽먼트 캄파니 리미티드	항 제3자 중심 기억 ｔ 세포, 이의 제조 방법, 및 이식 및 질환 치료에서의 이의 용도
US10806146B2 (en)	2011-09-13	2020-10-20	Monsanto Technology Llc	Methods and compositions for weed control
CA2848695A1 (fr)	2011-09-13	2013-03-21	Monsanto Technology Llc	Procede et composition de lutte contre les mauvaises herbes comprenant l'inhibition de la ppg oxydase
WO2013040057A1 (fr)	2011-09-13	2013-03-21	Monsanto Technology Llc	Procédés et compositions de lutte contre les mauvaises herbes
CA2848680C (fr)	2011-09-13	2020-05-19	Monsanto Technology Llc	Procedes et compositions de lutte contre les mauvaises herbes
US10760086B2 (en)	2011-09-13	2020-09-01	Monsanto Technology Llc	Methods and compositions for weed control
CN103957697B (zh)	2011-09-13	2017-10-24	孟山都技术公司	用于杂草控制的方法和组合物
US10829828B2 (en)	2011-09-13	2020-11-10	Monsanto Technology Llc	Methods and compositions for weed control
WO2013054320A1 (fr)	2011-10-11	2013-04-18	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
ES2638331T3 (es)	2011-10-21	2017-10-19	Augurex Life Sciences Corp.	Antígenos derivados de la proteína 14-3-3 citrulinada y usos de estos en el diagnóstico de la artritis reumatoide
US9145559B2 (en)	2011-10-27	2015-09-29	Yeda Research And Development Co. Ltd.	Methods of treating cancer
CN103917647B (zh)	2011-11-03	2020-07-10	夸克制药公司	用于神经保护的方法和组合物
EP2776565A1 (fr)	2011-11-08	2014-09-17	Quark Pharmaceuticals, Inc.	Méthodes et compositions destinées à traiter des maladies, des troubles ou une lésion du système nerveux
WO2013076729A1 (fr)	2011-11-23	2013-05-30	Danziger Dan Flower Farm	Plantes de type otomeria
EP2782930B1 (fr)	2011-11-27	2018-07-11	Yeda Research and Development Co. Ltd.	Méthodes de régulation de l'angiogenèse et compositions capables de réguler l'angiogenèse
AU2012348574A1 (en)	2011-12-08	2014-07-24	Yeda Research And Development Co. Ltd.	Mammalian fetal pulmonary cells and therapeutic use of same
WO2013093921A1 (fr)	2011-12-20	2013-06-27	Collplant Ltd.	Fibres de polymère synthétique enrobées de collagène
BR112014015960A8 (pt)	2011-12-22	2017-07-04	Yeda Res & Dev	método para tratamento de um indivíduo em necessidade de um enxerto de célula ou tecido não singênico, método para tratamento de um indivíduo em necessidade de um transplante hematopoiéticas, método para o tratamento de um indivíduo em necessidade de um enxerto de célula ou tecido não singênico, método para tratamento de um indivíduo em necessidade de um transplante de células hematopoiéticas imaturas, e método para indução de tolerância do doador específico em um indivíduo em necessidade de um enxerto de célula ou tecido não congênito
CN104254395B (zh)	2011-12-22	2016-05-04	生命科技公司	用于分析物测定的序贯侧向流动毛细管装置
US20150013029A1 (en)	2011-12-28	2015-01-08	Kaiima Bio Agritech Ltd.	Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
SG11201403756PA (en)	2012-01-01	2014-11-27	Qbi Entpr Ltd	Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
WO2013114363A2 (fr)	2012-01-30	2013-08-08	Yeda Research And Development Co.Ltd.	Agents antimicrobiens
WO2013114374A1 (fr)	2012-02-01	2013-08-08	Protalix Ltd.	Polypeptides d'adnase i, polynucléotides codant ces derniers, procédés de production d'adnase i et utilisations de celle-ci en thérapie
US10184131B2 (en)	2012-02-06	2019-01-22	A.B. Seeds Ltd.	Isolated polynucleotides expressing or modulating microRNAs or targets of same, transgenic plants comprising same and uses thereof
US10047345B2 (en)	2012-02-13	2018-08-14	Gamida-Cell Ltd.	Culturing of mesenchymal stem cells with FGF4 and nicotinamide
ES2665319T3 (es)	2012-02-14	2018-04-25	Opko Biologics Ltd.	Factores de coagulación de acción prolongada y métodos para producir los mismos
AU2013220005A1 (en)	2012-02-19	2014-09-04	Protalix Ltd.	Oral unit dosage forms and uses of same for the treatment of Gaucher disease
EP3401393B1 (fr)	2012-02-22	2020-02-19	Exostem Biotec Ltd	Microarn pour la génération d'astrocytes
EP2844745A2 (fr)	2012-02-22	2015-03-11	Brainstem Biotec Ltd.	Génération de cellules souches neuronales et de motoneurones
WO2013128454A1 (fr)	2012-03-01	2013-09-06	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center	Plantes d'ail stérile mâle, descendance hybride de celles-ci et procédés de génération et d'utilisation de celles-ci
US9631028B2 (en)	2012-03-07	2017-04-25	Yeda Research And Development Co. Ltd.	Compositions for inhibition of quiescin sulfhydryl oxidase (QSOX1) and uses of same
US9334308B2 (en)	2012-03-22	2016-05-10	Ramot At Tel-Aviv University Ltd.	PLIF multimeric peptides and uses thereof
CA2868238A1 (fr)	2012-04-18	2013-10-24	Ramot At Tel Aviv University Ltd.	Particules de glycosaminoglycane lipide pour la liberation d'acides nucleiques
BR112014025951A2 (pt)	2012-04-19	2017-07-11	Opko Biologics Ltd	variantes de oxintomodulina de longa ação e métodos de produção do mesmo
EP2841084B1 (fr)	2012-04-24	2018-05-30	Biokine Therapeutics Ltd.	Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
WO2013168164A1 (fr)	2012-05-09	2013-11-14	Yeda Research And Development Co. Ltd.	VARIANTS DE PRO-DOMAINE TACE EN TANT QU'INHIBITEUR DE TNF-α ET LEUR UTILISATION MÉDICALE
KR101937733B1 (ko)	2012-05-24	2019-01-11	마운트게이트 그룹 리미티드	광견병 감염의 방지 및 치료에 관한 조성물 및 방법
UY34822A (es)	2012-05-24	2013-12-31	Seeds Ltd Ab	Composiciones y métodos para silenciar la expresión genética
US9731048B2 (en)	2012-06-03	2017-08-15	Ben-Gurion University Of The Negev Research And Development Authority	Functionalized titanium binding peptides and implants coated with same
MX362432B (es)	2012-06-04	2019-01-17	Opko Biologics Ltd	Variantes de oxm pegilada.
EP2870110A1 (fr)	2012-07-03	2015-05-13	Nanospun Technologies Ltd.	Procédés et dispositifs pour l'adsorption et la biodégradation de pétrole
US9175266B2 (en)	2012-07-23	2015-11-03	Gamida Cell Ltd.	Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en)	2012-07-23	2017-02-14	Gamida Cell Ltd.	Methods of culturing and expanding mesenchymal stem cells
US10155933B2 (en)	2012-07-29	2018-12-18	Yeda Research And Development Co., Ltd.	Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
WO2014020608A1 (fr)	2012-07-31	2014-02-06	Yeda Research And Development Co. Ltd.	Procédés de diagnostic et de traitement de maladies du neurone moteur
EP2880151B1 (fr)	2012-08-06	2020-06-03	Brainstorm Cell Therapeutics Ltd.	Procédés de génération de cellules souches mésechymateuses qui sécrètent des facteurs neurotrophiques
WO2014033723A1 (fr)	2012-09-03	2014-03-06	A.B. Seeds Ltd.	Procédé d'amélioration de la tolérance au stress abiotique des plantes et plantes ainsi produites
WO2014041544A1 (fr)	2012-09-12	2014-03-20	Ramot At Tel-Aviv University Ltd.	Immunoparticules et procédés pour les produire et les utiliser
US11105809B2 (en)	2012-10-09	2021-08-31	Ramot At Tel-Aviv University Ltd.	Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
EP2908864B1 (fr)	2012-10-22	2019-12-11	Sabag-Rfa Ltd.	Composés de phosphate pour l'administration d'agents thérapeutiques dans des cellules vivantes et des noyaux cellulaires
EP3584259A1 (fr)	2012-10-24	2019-12-25	Yeda Research and Development Co., Ltd.	Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
US9926564B2 (en)	2012-10-29	2018-03-27	Yeda Research And Development Co. Ltd.	Aptamers, multimeric aptamers and uses thereof
BR112015011583B1 (pt)	2012-11-20	2023-03-14	Opko Biologics Ltd	Métodos para aumentar o tamanho ou volume hidrodinâmico de hormônio de crescimento humano, método para aumentar o peso molecular aparente de um polipeptídeo e método para aumentar a meia-vida de um polipeptídeo
WO2015079413A2 (fr)	2013-11-28	2015-06-04	Yeda Research And Development Co. Ltd.	Inhibiteurs de synaptojanine-2 et leurs utilisations
US20150290233A1 (en)	2012-11-29	2015-10-15	Yeda Research And Development Co.Ltd. At The Weizmann Institute Of Science	Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
US10683505B2 (en)	2013-01-01	2020-06-16	Monsanto Technology Llc	Methods of introducing dsRNA to plant seeds for modulating gene expression
CN105358695B (zh)	2013-01-01	2019-07-12	A.B.种子有限公司	将dsRNA引入植物种子以调节基因表达的方法
WO2014108854A1 (fr)	2013-01-09	2014-07-17	Fusimab Ltd.	Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
WO2014108850A2 (fr)	2013-01-09	2014-07-17	Yeda Research And Development Co. Ltd.	Analyse de transcriptome à haut débit
EP2946207B1 (fr)	2013-01-17	2018-05-16	Novellusdx Ltd.	Procédés et systèmes pour identifier des mutations conductrices spécifiques à un patient
WO2014118785A1 (fr)	2013-02-04	2014-08-07	Ramot At Tel-Aviv University Ltd.	Génération de lignées cellulaires spécifiques d'une tumeur cytotoxiques et leurs utilisations
WO2014136114A1 (fr)	2013-03-06	2014-09-12	Protalix Ltd.	Polypeptides inhibiteurs de tnf alpha, polynucléotides codant pour ceux-ci, cellules exprimant ceux-ci et leurs procédés de production
CA2902727C (fr)	2013-03-06	2020-08-18	Protalix Ltd.	Utilisation de cellules vegetales exprimant un inhibiteur du polypeptide tnf alpha en therapie
US10612019B2 (en)	2013-03-13	2020-04-07	Monsanto Technology Llc	Methods and compositions for weed control
UA123082C2 (uk)	2013-03-13	2021-02-17	Монсанто Текнолоджи Ллс	Спосіб та гербіцидна композиція для боротьби з видами рослин роду sorghum
US10568328B2 (en)	2013-03-15	2020-02-25	Monsanto Technology Llc	Methods and compositions for weed control
WO2014153394A1 (fr)	2013-03-21	2014-09-25	Genisphere, Llc	Administration cellulaire d'agents intercalants de l'adn
US10493134B2 (en)	2013-03-21	2019-12-03	Collplant Ltd.	Compositions comprising collagen and PRP for tissue regeneration
KR20150135432A (ko)	2013-03-24	2015-12-02	바이오카인 테라퓨틱스 리미티드	골수성 백혈병의 치료 방법
BR112015026702A2 (pt)	2013-04-21	2018-02-06	Yeda Res And Developmente Co Ltd	métodos de extermínio de células senescentes
US10920192B2 (en)	2013-04-23	2021-02-16	Yeda Research And Development Co. Ltd.	Isolated naive pluripotent stem cells and methods of generating same
CN105555796B (zh)	2013-04-25	2019-09-17	耶达研究及发展有限公司	抑制肽对治疗炎性疾病的用途
WO2014188423A1 (fr)	2013-05-21	2014-11-27	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Traitement de pathologies associées aux mastocytes
HRP20192284T1 (hr)	2013-05-27	2020-03-06	Rakuto Bio Technologies Ltd.	Kozmetički sastavi koji sadrže enzimski sustav
WO2014207744A1 (fr)	2013-06-24	2014-12-31	Ramot At Tel-Aviv University Ltd.	Échafaudage à base d'épiploon et système d'administration
JP6668236B2 (ja)	2013-07-19	2020-03-18	モンサントテクノロジーエルエルシー	Ｌｅｐｔｉｎｏｔａｒｓａ防除用組成物及びその方法
US9850496B2 (en)	2013-07-19	2017-12-26	Monsanto Technology Llc	Compositions and methods for controlling Leptinotarsa
WO2015015489A1 (fr)	2013-07-30	2015-02-05	Biolinerx Ltd.	Anticorps convenant au traitement du diabète et de maladies autoimmunes
US9938316B2 (en)	2013-08-29	2018-04-10	Yeda Research And Development Co. Ltd.	Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
IL228284A (en)	2013-09-03	2016-12-29	Technion Res & Dev Foundation	Implants from cellular scaffolding and blood vessel stalk
US20160251410A1 (en)	2013-09-03	2016-09-01	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Compositions and methods for expressing recombinant polypeptides
WO2015033344A1 (fr)	2013-09-05	2015-03-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
WO2015037009A1 (fr)	2013-09-16	2015-03-19	Plexicure Ltd.	Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
US9695402B2 (en)	2013-09-17	2017-07-04	Yeda Research And Development Co. Ltd.	ERK-derived peptides and uses thereof
KR20160058822A (ko)	2013-10-01	2016-05-25	카디마스템 리미티드	약물 스크리닝 및 근위축성 측삭 경화증 (ａｌｓ) 의 치료에서 사용하기 위한 인간 다능성 줄기 세포로부터의 성상세포의 유도 분화
EP3055066A4 (fr)	2013-10-07	2017-06-14	Yeda Research and Development Co., Ltd.	Dispositif microfluidique pour analyser l'expression de gènes
TWI777407B (zh)	2013-10-21	2022-09-11	以色列商歐科生物製品有限公司	長效型多肽及其生產和給藥的方法
US20150158926A1 (en)	2013-10-21	2015-06-11	Opko Biologics, Ltd.	Long-acting polypeptides and methods of producing and administering same
EP3060656A1 (fr)	2013-10-24	2016-08-31	Yeda Research and Development Co., Ltd.	Polynucléotides codant pour des polypeptides de système brex et leurs méthodes d'utilisation
CN106029084A (zh)	2013-10-31	2016-10-12	百欧肯治疗有限公司	治疗具有类fms酪氨酸激酶3突变的急性骨髓性白血病的方法
WO2015066681A1 (fr)	2013-11-04	2015-05-07	Monsanto Technology Llc	Compositions et procédés de lutte contre les infestations de parasites de type arthropode et d'organismes nuisibles
ES2754207T3 (es)	2013-11-28	2020-04-16	Tel Hashomer Medical Res Infrastructure & Services Ltd	Inhibidores de la ARN polimerasa I y usos de los mismos
WO2015087327A1 (fr)	2013-12-10	2015-06-18	Yeda Research And Development Co. Ltd.	Utilisation d'enzymes catalysant la synthèse de pyruvate à partir de formiate et d'acétyl-coa et bactéries les exprimant
UA119253C2 (uk)	2013-12-10	2019-05-27	Біолоджикс, Інк.	Спосіб боротьби із вірусом у кліща varroa та у бджіл
AR099092A1 (es)	2014-01-15	2016-06-29	Monsanto Technology Llc	Métodos y composiciones para el control de malezas utilizando polinucleótidos epsps
WO2015114633A1 (fr)	2014-01-30	2015-08-06	Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd.	Peptides se liant à l'actine et compositions les contenant pour inhiber l'angiogenèse et traiter des affections médicales associées à celle-ci
AU2015212341A1 (en)	2014-02-03	2016-09-08	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Use of Casein kinase I inhibitors for depleting stem cells
CN111733231A (zh)	2014-02-05	2020-10-02	耶达研究及发展有限公司	用于治疗和诊断的微rna和包含所述微rna的组合物
WO2015118538A1 (fr)	2014-02-06	2015-08-13	Yeda Research And Development Co. Ltd.	Anticorps anti cd84, compositions les comprenant et leurs utilisations
WO2015118547A1 (fr)	2014-02-10	2015-08-13	Protalix Ltd.	Méthode de maintien de la stabilité d'une maladie chez un sujet atteint de la maladie de gaucher
WO2015121859A1 (fr)	2014-02-11	2015-08-20	Brainstorm Cell Therapeutics Ltd.	Procédé de qualification de cellules
EP3114483A1 (fr)	2014-03-03	2017-01-11	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Procédé et dispositif de détection de pseudomonas aeruginosa
EP2923709A1 (fr)	2014-03-28	2015-09-30	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Vaccin contre la malaria multi-composants-multi-étapes
CN106413390B (zh)	2014-04-01	2019-09-27	孟山都技术公司	用于控制虫害的组合物和方法
AU2015245963B2 (en)	2014-04-10	2019-02-28	Bonus Therapeutics Ltd.	Bone repair compositions
EP4306659A3 (fr)	2014-04-14	2024-03-27	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Procédé et kit pour déterminer l'origine tissulaire ou cellulaire d'adn
WO2015159295A1 (fr)	2014-04-17	2015-10-22	Yeda Research And Development Co. Ltd.	Procédés et kits pour analyser les fragments se liant à l'adn liés à l'adn
MD20160130A2 (ro)	2014-04-27	2017-04-30	Ccam Biotherapeutics Ltd.	Anticorpi umanizaţi contra CEACAM1
US11427647B2 (en)	2014-04-27	2022-08-30	Famewave Ltd.	Polynucleotides encoding humanized antibodies against CEACAM1
US20160263166A1 (en)	2014-04-28	2016-09-15	Yeda Research And Development Co., Ltd.	Microbiome response to agents
SG11201609039QA (en)	2014-05-04	2016-11-29	Forrest Innovations Ltd	Compositions for mosquito control and uses of same
US10294482B2 (en)	2014-05-22	2019-05-21	Yeda Research And Development Co. Ltd.	Recombinant microorganisms capable of carbon fixation
US20170253881A1 (en)	2014-06-02	2017-09-07	Technion Research & Development Foundation Limited	Compositions and methods of selectively inhibiting irp1 and treating inflammation
US20170095512A1 (en)	2014-06-02	2017-04-06	Kadimastem Ltd.	Methods of inducing myelination and maturation of oligodendrocytes
US10988764B2 (en)	2014-06-23	2021-04-27	Monsanto Technology Llc	Compositions and methods for regulating gene expression via RNA interference
US20170183376A1 (en)	2014-06-24	2017-06-29	Insight Biopharmaceuticals Ltd.	Methods of purifying antibodies
US10883994B2 (en)	2014-06-25	2021-01-05	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Identification of cancer stem cells markers and use of same for diagnosis and treatment
WO2015200539A1 (fr)	2014-06-25	2015-12-30	Monsanto Technology Llc	Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
JP2017520549A (ja)	2014-06-26	2017-07-27	ラモットアットテルアビブユニバーシティ，リミテッド	核酸の送達のためのリポソーム製剤
WO2016005985A2 (fr)	2014-07-09	2016-01-14	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Méthode pour reprogrammer des cellules
CA2951984C (fr)	2014-07-15	2023-10-03	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Polypeptides isoles de cd44 et utilisations associees
JP6837428B2 (ja)	2014-07-21	2021-03-10	ノベルラスディクスリミテッド	患者特有の変異の発癌性指数を決定する方法およびシステム
CN106715719B (zh)	2014-07-21	2022-08-02	福尔生物治疗有限公司	用于确定患者特定突变的药物反应的方法
US10378012B2 (en)	2014-07-29	2019-08-13	Monsanto Technology Llc	Compositions and methods for controlling insect pests
JP2017525351A (ja)	2014-07-30	2017-09-07	イェダリサーチアンドディベロップメントカンパニーリミテッドＹｅｄａＲｅｓｅａｒｃｈＡｎｄＤｅｖｅｌｏｐｍｅｎｔＣｏ．Ｌｔｄ．	多能性幹細胞の培養用培地
EP3699930B1 (fr)	2014-08-14	2024-02-07	MeMed Diagnostics Ltd.	Analyse computationnelle de données biologiques au moyen d'un collecteur et d'un hyperplan
WO2016030899A1 (fr)	2014-08-28	2016-03-03	Yeda Research And Development Co. Ltd.	Méthodes de traitement de la sclérose latérale amyotrophique
CA2959775A1 (fr)	2014-09-08	2016-03-17	Yeda Research And Development Co. Ltd.	Compositions et procedes de traitement d'un cancer resistant a un inhibiteur de la tyrosine kinase (tki)
WO2016038609A1 (fr)	2014-09-08	2016-03-17	Yeda Research And Development Co. Ltd.	Anticorps anti-her3 et leurs utilisations
EP2992895A1 (fr)	2014-09-08	2016-03-09	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Vaccin contre la malaria multi-composants-multi-étapes
US20170283844A1 (en)	2014-09-11	2017-10-05	The State of Israel, Ministry of Agriculture & Rural Development, Argricultural Research Organiza	Methods of producing mogrosides and compositions comprising same and uses thereof
IL234638A0 (en)	2014-09-14	2014-12-02	Yeda Res & Dev	NMDA receptor antagonists for the treatment of Gaucher disease
WO2016042561A2 (fr)	2014-09-21	2016-03-24	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Freination du mir-132 pour le traitement de troubles lipidiques
US10093989B2 (en)	2014-10-20	2018-10-09	Gen-Probe Incorporated	Red blood cell lysis solution
EP3217785B1 (fr)	2014-11-13	2023-10-25	Enzootic Holdings Ltd.	Inversion de sexe fonctionnelle de femelles crustacés décapodes
CN107429291A (zh)	2014-11-17	2017-12-01	耶达研究及发展有限公司	分析微生物组的方法
EP3220945A2 (fr)	2014-11-17	2017-09-27	Yeda Research and Development Co., Ltd.	Procédés de traitement de maladies associées à une fonction mitochondriale
CN107810271B (zh)	2014-11-20	2021-09-28	耶路撒冷希伯来大学伊萨姆研发公司	用于在植物细胞中生产具有改变的糖基化模式的多肽的组合物和方法
WO2016084088A1 (fr)	2014-11-26	2016-06-02	Ramot At Tel-Aviv University Ltd.	Élimination ciblée de gènes bactériens
EP3224363B1 (fr)	2014-11-27	2021-11-03	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Construction d'acide nucléique pour l'édition de génome
SG11201704706RA (en)	2014-12-10	2017-07-28	Opko Biologics Ltd	Methods of producing long acting ctp-modified growth hormone polypeptides
EP3230740B1 (fr)	2014-12-11	2025-05-21	Memed Diagnostics Ltd.	Combinaisons de marqueurs de diagnostic d'infections et leurs méthodes d'utilisation
WO2016092555A2 (fr)	2014-12-11	2016-06-16	Yeda Research And Development Co. Ltd.	Polypeptides de phosphotriestérase isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition aux organophosphates
WO2016103269A1 (fr)	2014-12-23	2016-06-30	Ramot At Tel-Aviv University Ltd.	Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
IL253244B2 (en)	2014-12-30	2023-09-01	Cell Cure Neurosciences Ltd	Methods for treating retinal diseases
CA2972580A1 (fr)	2014-12-30	2016-07-07	Cell Cure Neurosciences Ltd.	Evaluation de populations de cellules epitheliales pigmentaires retiniennes
IL321407A (en)	2014-12-30	2025-08-01	Cell Cure Neurosciences Ltd	RPE cell populations and methods for their production
AU2016204793B2 (en)	2015-01-04	2021-12-16	Protalix Ltd.	Modified DNase and uses thereof
WO2016116935A1 (fr)	2015-01-21	2016-07-28	Yeda Research And Development Co. Ltd.	Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
JP6942632B2 (ja)	2015-01-22	2021-09-29	モンサントテクノロジーエルエルシー	Ｌｅｐｔｉｎｏｔａｒｓａ防除用組成物及びその方法
US20180345047A1 (en)	2015-02-26	2018-12-06	Yeda Research And Development Co. Ltd.	Method of promoting hair growth
US10781445B2 (en)	2015-03-11	2020-09-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Decoy oligonucleotides for the treatment of diseases
IL237852A0 (en)	2015-03-19	2016-03-24	Yeda Res & Dev	Antibodies against amphigoline, medical preparations containing them and their use
EP3273971A4 (fr)	2015-03-27	2018-12-05	Yeda Research and Development Co. Ltd.	Méthodes de traitement des maladies des motoneureones
EP3273994B1 (fr)	2015-03-27	2021-12-01	University of Southern California	Thérapie à base de lymphocytes t car dirigés contre le récepteur lhr pour le traitement des tumeurs solides
AU2016242298A1 (en)	2015-03-31	2017-10-19	Yeda Research And Development Co. Ltd.	Glutamate Oxaloacetate Transaminase 1 (GOT1), preparations and methods of generating same and uses thereof
US10960035B2 (en)	2015-04-01	2021-03-30	The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center)	Erodium crassifolium L'Her plant extracts and uses thereof
AU2016245434B2 (en)	2015-04-07	2020-10-29	Ela Pharma Ltd	Compositions for treating and/or preventing cell or tissue necrosis specifically targeting Cathepsin C and/or CELA1 and/or CELA3A and/or structurally related enzymes thereto
EP3081575A1 (fr)	2015-04-12	2016-10-19	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Anticorps anti-plasmodium pour parasite
ES2951653T3 (es)	2015-04-27	2023-10-24	Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct	Moléculas dirigidas a EGR1 para el tratamiento de afecciones inflamatorias e hiperproliferativas
WO2016174673A1 (fr)	2015-04-29	2016-11-03	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)	Compositions anti-phytopathogènes
US20190031759A1 (en)	2015-04-30	2019-01-31	Technion Research & Development Foundation Limited	Chimeric antigen receptors and methods of their use
CN108026566A (zh)	2015-05-04	2018-05-11	特拉维夫大学拉莫特有限公司	用于使dna片段化的方法和试剂盒
EP3294280A1 (fr)	2015-05-11	2018-03-21	Yeda Research and Development Co., Ltd.	Inhibiteurs de citrine pour le traitement du cancer
EP3298141A4 (fr)	2015-05-17	2019-01-09	The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center	Compositions et méthodes de traitement du cancer
WO2016185457A1 (fr)	2015-05-19	2016-11-24	Yeda Research And Development Co. Ltd.	Méthodes pour favoriser la lymphagiogenèse
WO2016185481A2 (fr)	2015-05-20	2016-11-24	Yeda Research And Development Co. Ltd.	Procédé destiné à cibler des cellules sénescentes
JP2018515564A (ja)	2015-05-21	2018-06-14	イェダリサーチアンドディベロップメントカンパニーリミテッドＹｅｄａＲｅｓｅａｒｃｈＡｎｄＤｅｖｅｌｏｐｍｅｎｔＣｏ．Ｌｔｄ．	健康増進のための細菌群
AU2016273045B2 (en)	2015-05-29	2020-11-26	Opko Biologics Ltd.	Pegylated oxyntomodulin variants
WO2016196738A1 (fr)	2015-06-02	2016-12-08	Monsanto Technology Llc	Compositions et procédés pour l'administration d'un polynucléotide dans une plante
EP3302030A4 (fr)	2015-06-03	2019-04-24	Monsanto Technology LLC	Procédés et compositions pour l'introduction d'acides nucléiques dans des plantes
EP3302559B1 (fr)	2015-06-04	2022-01-12	University of Southern California	Immunothérapie des cellules car ciblées par lym-1 et lym-2
NL2014935B1 (en)	2015-06-08	2017-02-03	Applied Immune Tech Ltd	T cell receptor like antibodies having fine specificity.
US10668109B2 (en)	2015-06-18	2020-06-02	Yeda Research And Development Co. Ltd.	Conditioning protocols and use of same for tissue regeneration
WO2016203476A1 (fr)	2015-06-18	2016-12-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
HUE055449T2 (hu)	2015-06-19	2021-11-29	Opko Biologics Ltd	Hosszú hatástartamú koagulációs faktorok és eljárások ezek elõállítására
US10682390B2 (en)	2015-07-16	2020-06-16	Biokine Therapeutics Ltd.	Compositions and methods for treating cancer
PL3322425T3 (pl)	2015-07-16	2023-10-09	Yeda Research And Development Co., Ltd.	Zmodyfikowane genetycznie, skierowane przeciwko osobie trzeciej centralne limfocyty T pamięci i ich zastosowanie w immunoterapii
US10668094B2 (en)	2015-07-19	2020-06-02	Yeda Research And Development Co. Ltd.	Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
CN107846936B (zh)	2015-07-22	2021-06-01	芙图法尔马国际有限公司	蜜蜂可摄取组成物及使用其生产蜂蜜的方法与由此生产的蜂蜜
US11230696B2 (en)	2015-07-29	2022-01-25	Hadasit Medical Research Services And Development Ltd.	Large scale production of retinal pigment epithelial cells
ES2965461T3 (es)	2015-08-03	2024-04-15	Biokine Therapeutics Ltd	Inhibidor de CXCR4 para el tratamiento del cáncer
WO2017021961A1 (fr)	2015-08-04	2017-02-09	Yeda Research And Development Co. Ltd.	Procédés de criblage pour riborégulateurs et atténuateurs
AU2016303632B2 (en)	2015-08-05	2022-09-29	Cell Cure Neurosciences Ltd.	Preparation of retinal pigment epithelium cells
EP3331995A1 (fr)	2015-08-05	2018-06-13	Cell Cure Neurosciences Ltd.	Préparation de photorécepteurs pour le traitement de maladies rétiniennes
US10639350B2 (en)	2015-08-10	2020-05-05	The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center	Methods and pharmaceutical compositions for improving wound healing using CD24
EP3334831A1 (fr)	2015-08-13	2018-06-20	Forrest Innovations Ltd.	Formulations et compositions d'administration d'acides nucléiques à des cellules végétales
WO2017033188A1 (fr)	2015-08-24	2017-03-02	Yeda Research And Development Co. Ltd.	Huile et biocarburant d'origine algale et leurs procédés de production
US10765706B2 (en)	2015-09-03	2020-09-08	University Of South Florida	Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
WO2017042816A1 (fr)	2015-09-10	2017-03-16	Yeda Research And Development Co. Ltd.	Ablation de cellules dendritiques dont le test est positif pour la perforine, dans le traitement du cancer
WO2017072757A1 (fr)	2015-10-25	2017-05-04	Yeda Research And Development Co. Ltd.	Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
EP4545633A3 (fr)	2015-10-26	2025-07-09	Cell Cure Neurosciences Ltd.	Préparation de cellules de l'épithélium pigmentaire rétinien
US11090275B2 (en)	2015-10-27	2021-08-17	Jay Pharma Inc.	Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
IL242380A0 (en)	2015-10-29	2016-02-01	Yeda Res & Dev	A method for inducing the division of cardiomyocytes and treating heart diseases
EP3370791A1 (fr)	2015-11-03	2018-09-12	Ariel-University Research and Development Company Ltd.	Compositions destinées à la régénération et à la réparation de tissu nerveux
EP3374524B1 (fr)	2015-11-11	2025-01-29	Ramot at Tel-Aviv University Ltd.	Procédés de détection de la 5-hydroxyméthylcytosine et diagnostic du cancer
EP3384286B1 (fr)	2015-11-30	2023-04-19	Kadimastem Ltd.	Procédés de différenciation et de purification de cellules endocrines pancréatiques
US10228367B2 (en)	2015-12-01	2019-03-12	ProteinSimple	Segmented multi-use automated assay cartridge
EP3176183A1 (fr)	2015-12-02	2017-06-07	Yeda Research and Development Co. Ltd	Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
ES2924732T3 (es)	2015-12-16	2022-10-10	Univ Ramot	Partículas que comprenden epiplón descelularizado
EP3397344A4 (fr)	2015-12-28	2019-08-28	B.G. Negev Technologies and Applications Ltd. at Ben-Gurion University	Composition et méthode pour le traitement de la sclérose latérale amyotrophique
CN108697907A (zh)	2016-01-06	2018-10-23	耶达研究及发展有限公司	用于治疗恶性疾病、自身免疫疾病和炎性疾病的组合物和方法
WO2017122203A1 (fr)	2016-01-11	2017-07-20	Technion Research & Development Foundation Limited	Méthodes de détermination du pronostic de septicémie et traitement associé
MX2018008910A (es)	2016-01-21	2019-03-28	The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo	Plantas partenocarpicas y procedimientos de produccion de las mismas.
IL243839B (en)	2016-01-28	2018-01-31	Sp Nano Ltd	Conductive wires
IL243838A (en)	2016-01-28	2017-07-31	Sp Nano Ltd	The composition containing sp1 protein and carbon nanoparticles and its uses
WO2017130205A1 (fr)	2016-01-31	2017-08-03	Hadasit Medical Research Services And Development Ltd.	Populations de cellules souches pluripotentes ayant une composition de chromosomes sexuels non identiques et leurs utilisations
CA3012302A1 (fr)	2016-02-04	2017-08-10	Yeda Research And Development Co. Ltd.	Peptides et leur utilisation dans le traitement de maladies, troubles ou affections associes a un p53 mutant
US20190142875A1 (en)	2016-02-14	2019-05-16	Yeda Research And Development Co. Ltd.	Microbiome-based diagnosis, prediction and treatment of relapsing obesity
WO2017138008A2 (fr)	2016-02-14	2017-08-17	Yeda Research And Development Co. Ltd.	Procédés de modulation de l'exocytose de protéines et utilisations associées en thérapie
CN109152366A (zh)	2016-02-16	2019-01-04	耶路撒冷希伯来大学伊萨姆研发有限公司	用于抑制蓝细菌和植物生长的非蛋白苯丙氨酸类似物
EP3416671A4 (fr)	2016-02-19	2019-10-30	Genisphere, LLC	Vecteurs d'acide nucléique et leurs procédés thérapeutiques d'utilisation
JP2019511919A (ja)	2016-02-23	2019-05-09	ブローディ，チャヤ	がん幹細胞の作製およびその使用
WO2017149538A1 (fr)	2016-03-01	2017-09-08	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Anticorps spécifiques du récepteur du poliovirus humain (pvr)
IL294121B2 (en)	2016-03-03	2023-09-01	Memed Diagnostics Ltd	An RNA test to diagnose the type of infection
WO2017153982A1 (fr)	2016-03-06	2017-09-14	Yeda Research And Development Co. Ltd.	Procédé de modulation de la myélinisation
IL244649A0 (en)	2016-03-17	2016-06-30	Yeda Res & Dev	Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
EP3440461A4 (fr)	2016-04-06	2019-11-06	Technion Research & Development Foundation Limited	Prédiction de la réponse anti-tnf dans des biopsies de côlon avec les proportions de cellules immunitaires infiltrantes
US10421785B2 (en)	2016-04-11	2019-09-24	Bar-Ilan University	Delta receptor agonist peptides and use thereof
EP3736332B1 (fr)	2016-04-27	2025-02-12	Gen-Probe Incorporated	Réactif de lyse de cellules sanguines
EP3463402B1 (fr)	2016-05-22	2021-06-23	Yeda Research and Development Co. Ltd.	Méthodes d'utilisation de cellules pulmonaires pour transplantation et induction de tolérance
IL245861A0 (en)	2016-05-25	2016-09-04	Yeda Res & Dev	Use of substances to treat drug-resistant tumors
US20190100732A1 (en)	2016-06-02	2019-04-04	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Assay for the removal of methyl-cytosine residues from dna
WO2017212476A1 (fr)	2016-06-05	2017-12-14	Tel Hashomer Medical Research Infrastructure And Services Ltd.	Nouvelles molécules destinées au traitement de l'inflammation
EP3468610A1 (fr)	2016-06-09	2019-04-17	OPKO Biologics Ltd.	Formulation d'oxyntomoduline à action prolongée, et procédés de production et procédés d'administration de cette dernière
WO2017221225A1 (fr)	2016-06-19	2017-12-28	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Criblage de la résistance à la chimiothérapie dans des cellules haploïdes humaines
AU2017289879B2 (en)	2016-06-27	2023-04-20	Yeda Research And Development Co. Ltd.	Veto cells generated from memory T cells
WO2018011795A1 (fr)	2016-07-10	2018-01-18	Memed Diagnostics Ltd.	Signatures de protéines permettant d'établir la différence entre des infections bactériennes et des infections virales
US11340223B2 (en)	2016-07-10	2022-05-24	Memed Diagnostics Ltd.	Early diagnosis of infections
CN109689893A (zh)	2016-07-11	2019-04-26	博纳斯治疗公司	用于组织再生的细胞组合物
IL246722A0 (en)	2016-07-11	2016-09-29	Yeda Res & Dev	Combination therapy to increase endogenous nitric oxide (no) synthesis
EP3481855B1 (fr)	2016-07-11	2023-09-06	OPKO Biologics Ltd.	Facteur vii de coagulation à action prolongée et procédés de production associés
WO2018011805A2 (fr)	2016-07-11	2018-01-18	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Systèmes et procédés de culture de cellules in vitro
ES3034904T3 (en)	2016-07-18	2025-08-27	Univ Ramot	Modular platform for targeted therapeutics
WO2018020489A1 (fr)	2016-07-24	2018-02-01	Yeda Research And Development Co. Ltd.	Méthodes et kits pour analyser des fragments de liaison à l'adn liés à l'adn
US10982252B2 (en)	2016-08-08	2021-04-20	Technology Innovation Momentum Fund (Israel) Limited Partnership	Bacterial systems for analyzing ubiquitylated polypeptides
EP4033248B1 (fr)	2016-08-10	2024-04-10	MeMed Diagnostics Ltd.	Système et procédé d'analyse de mx1 et crp dans le sang
US10633706B2 (en)	2016-08-10	2020-04-28	Ramot At Tel-Aviv University Ltd.	Analysis of methylation status and copy number
SG11201901272WA (en)	2016-08-14	2019-03-28	Univ Ramot	Mesenchymal cell-derived exosomes to treat neurological disorders
IL247368A0 (en)	2016-08-18	2016-11-30	Yeda Res & Dev	Diagnostic and therapeutic uses of exosomes
WO2018037416A1 (fr)	2016-08-25	2018-03-01	Yeda Research And Development Co. Ltd.	Procédés et compositions pour le traitement de maladies auto-immunes
WO2018042425A1 (fr)	2016-08-28	2018-03-08	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)	Procédé de lutte contre les infections fongiques chez les plantes
EP3510047A1 (fr)	2016-09-07	2019-07-17	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Anticorps anti-nkp46 et leur utilisation thérapeutique
EP3512943B1 (fr)	2016-09-14	2023-04-12	Yeda Research and Development Co. Ltd.	Crisp-seq, procédé intégré pour séquençage massivement parallèle d'arn unicellulaire et criblages regroupés par crispr
WO2018060998A1 (fr)	2016-09-29	2018-04-05	Memed Diagnostics Ltd.	Méthodes de pronostic et de traitement
IL248468A0 (en)	2016-10-13	2017-01-31	Technion Res & Dev Foundation	Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
IL248385A0 (en)	2016-10-18	2017-02-01	Yeda Res & Dev	Treatment of circadian rhythm disorder
US20190359956A1 (en)	2016-11-10	2019-11-28	Yeda Research And Development Co. Ltd.	Phosphotriesterases for treating or preventing organophosphate exposure associated damage
EP3545095A1 (fr)	2016-11-28	2019-10-02	Yeda Research and Development Co., Ltd.	Polynucléotides et polypeptides isolés et procédés pour les utiliser afin d'exprimer un produit d'expression d'intérêt
WO2018100574A1 (fr)	2016-11-30	2018-06-07	Yeda Research And Development Co. Ltd.	Méthodes de traitement de maladies et de la toxicité hépathique
AU2017368911B2 (en)	2016-12-01	2022-03-10	Ramot At Tel-Aviv University Ltd.	Combined treatment for nerve injuries
WO2018134824A1 (fr)	2017-01-18	2018-07-26	Yeda Research And Development Co. Ltd.	Cellules veto génétiquement modifiées et leur utilisation en immunothérapie
CN110234997B (zh)	2017-01-25	2023-06-16	St创新诊断有限公司	诊断恶性疾病的方法
IL250479A0 (en)	2017-02-06	2017-03-30	Sorek Rotem	Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
IL268357B2 (en)	2017-02-08	2025-07-01	Hadasit Med Res Service	Photoreceptor cells for the treatment of retinal diseases
IL250916A0 (en)	2017-03-02	2017-06-29	Geiger Benjamin	Methods for growing t cells in culture and their use
WO2018167780A1 (fr)	2017-03-12	2018-09-20	Yeda Research And Development Co. Ltd.	Méthodes de diagnostic et de traitement du cancer
EP3596469A1 (fr)	2017-03-12	2020-01-22	Yeda Research and Development Co., Ltd.	Procédés de diagnostic et de pronostic du cancer
WO2018170494A1 (fr)	2017-03-16	2018-09-20	Bio Time, Inc.	Procédés de mesure d'effets thérapeutiques de traitements de maladies rétiniennes
JP7616798B2 (ja)	2017-04-05	2025-01-17	イェダリサーチアンドディベロップメントカンパニーリミテッド	エクスビボ培養系およびその使用方法
IL252151A0 (en)	2017-05-07	2017-07-31	Fainzilber Michael	Treatment of stress disorders
JP7445429B2 (ja)	2017-05-10	2024-03-07	アリエルサイエンティフィックイノベーションズリミテッド	抗体の精製法
WO2018216006A1 (fr)	2017-05-21	2018-11-29	The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center	Combinaison de marqueurs pour diagnostiquer un cancer
WO2018216011A1 (fr)	2017-05-23	2018-11-29	Technion Research & Development Foundation Limited	Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
GB201708662D0 (en)	2017-05-31	2017-07-12	Tropic Biosciences Uk Ltd	Compositions and methods for increasing shelf-life of banana
GB201708665D0 (en)	2017-05-31	2017-07-12	Tropic Biosciences Uk Ltd	Compositions and methods for increasing extractability of solids from coffee beans
US20200109408A1 (en)	2017-05-31	2020-04-09	Tropic Biosciences UK Limited	Methods of selecting cells comprising genome editing events
WO2018229764A1 (fr)	2017-06-13	2018-12-20	Yeda Research And Development Co. Ltd.	Traitement de la sclérose en plaques avancée ou progressive
US11466323B2 (en)	2017-07-13	2022-10-11	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Dual-probe digital droplet PCR strategy for specific detection of tissue-specific circulating DNA molecules
EP4403646A3 (fr)	2017-07-13	2025-01-08	Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.	Cibles d'adn en tant que marqueurs de méthylation spécifiques de tissu
WO2019012542A1 (fr)	2017-07-13	2019-01-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Détection d'adn spécifique d'un tissu
IL253642A0 (en)	2017-07-24	2017-09-28	Seger Rony	Combined treatment for cancer
WO2019030759A1 (fr)	2017-08-08	2019-02-14	Technology Innovation Momentum Fund (Israel) Limited Partnership	Protéine tronquée résistante au chloramphénicol et ses utilisations
IL253984A0 (en)	2017-08-14	2017-09-28	Yeda Res & Dev	Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
CA3073254A1 (fr)	2017-08-21	2019-02-28	Savicell Diagnostic Ltd.	Procedes pour le diagnostic et le traitement du cancer du poumon
US11692166B2 (en)	2017-08-23	2023-07-04	Technion Research & Development Foundation Limited	Compositions and methods for improving alcohol tolerance in yeast
CN114958913A (zh)	2017-09-19	2022-08-30	以色列农业和农村发展部农业研究组织(范卡尼中心)	经过基因组编辑的鸟
AU2018336128B2 (en)	2017-09-19	2023-01-05	Tropic Biosciences UK Limited	Modifying the specificity of plant non-coding RNA molecules for silencing gene expression
CN111565731B (zh)	2017-10-24	2024-03-08	达莉亚·伊兰妮	治疗缺血性疾病的方法
WO2019094595A2 (fr)	2017-11-09	2019-05-16	Pinteon Therapeutics Inc.	Méthodes et compositions pour la génération et l'utilisation d'anticorps tau phosphorylés spécifiques à une conformation humanisée
IL255664A0 (en)	2017-11-14	2017-12-31	Shachar Idit	Hematopoietic stem cells with enhanced properties
EP3716756A4 (fr)	2017-11-29	2021-09-15	Weedout Ltd.	Compositions, kits et procédés de lutte contre les mauvaises herbes du genre amaranthus
US20200390800A1 (en)	2017-11-29	2020-12-17	Ramot At Tel-Aviv University Ltd.	Methods of preventing or treating neurogenic shock
WO2019106680A1 (fr)	2017-12-03	2019-06-06	Yeda Research And Development Co. Ltd.	Traitement d'une maladie cardiaque ischémique
WO2019116376A1 (fr)	2017-12-17	2019-06-20	Yeda Research And Development Co. Ltd.	Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
WO2019130313A1 (fr)	2017-12-28	2019-07-04	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
IL257225A (en)	2018-01-29	2018-04-09	Yeda Res & Dev	Treatment of sarcoma
CA3087291A1 (fr)	2018-01-29	2019-08-01	Lavie Bio Ltd.	Preparations microbiennes vegetales, compositions et formulations les comprenant et leurs utilisations
IL257269A (en)	2018-01-31	2018-04-09	Olender Tsviya	Signaling is directed to the endoplasmic reticulum
WO2019155459A1 (fr)	2018-02-08	2019-08-15	Yeda Research And Development Co. Ltd.	Inhibiteurs du protéasome 20s
WO2019155465A1 (fr)	2018-02-08	2019-08-15	Yeda Research And Development Co. Ltd.	Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
US11571433B2 (en)	2018-02-23	2023-02-07	Carmel Haifa University Economic Corporation Ltd.	Methods for treating memory impairment and cognitive dysfunction
WO2019167047A1 (fr)	2018-02-28	2019-09-06	The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center	Méthodes de diagnostic et de traitement du cancer de la vessie
WO2019175869A1 (fr)	2018-03-12	2019-09-19	Yeda Research And Development Co. Ltd	Traitement d'une maladie cardiaque
CN112566642B (zh)	2018-03-14	2025-01-17	纪念斯隆凯特琳癌症中心	抗聚唾液酸抗体及其用途
WO2019186569A1 (fr)	2018-03-29	2019-10-03	Yeda Research And Development Co. Ltd.	Utilisation de gradients de champ électrique pour commander l'expression génique
WO2019186558A1 (fr)	2018-03-29	2019-10-03	Technion Research And Development Foundation Limited	Vésicules comprenant un inhibiteur de pten et leurs utilisations
IL258467A (en)	2018-03-29	2018-07-04	Ilana Kolodkin Gal	Methods of disrupting a biofilm and/or preventing formation of same
GB201807192D0 (en)	2018-05-01	2018-06-13	Tropic Biosciences Uk Ltd	Compositions and methods for reducing caffeine content in coffee beans
WO2019220441A1 (fr)	2018-05-15	2019-11-21	Hadasit Medical Research Services And Development Ltd.	Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
IL259392A (en)	2018-05-15	2018-08-01	Yeda Res & Dev	Vaccination with cancer neoantigens
AU2019277908A1 (en)	2018-05-27	2021-01-07	Biolinerx Ltd.	AGI-134 combined with a checkpoint inhibitor for the treatment of solid tumors
EP3785279A4 (fr)	2018-05-31	2022-07-27	Immunity Pharma Ltd.	Compositions et leurs méthodes d'utilisation pour le traitement de la sclérose latérale amyotrophique (sla)
US11827892B2 (en)	2018-06-07	2023-11-28	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)	Nucleic acid constructs and methods of using same
WO2019234750A1 (fr)	2018-06-07	2019-12-12	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)	Procédés de régénération et de transformation de cannabis
WO2020003311A1 (fr)	2018-06-25	2020-01-02	Yeda Research And Development Co. Ltd.	Systèmes et procédés permettant d'améliorer l'efficacité de l'édition génomique
AU2019297677B2 (en)	2018-07-04	2024-11-07	Ukko Inc.	Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
US20210269860A1 (en)	2018-07-08	2021-09-02	Yeda Research And Development Co. Ltd.	Person-specific assessment of probiotics responsiveness
ES3026158T3 (en)	2018-07-11	2025-06-10	Immunity Pharma Ltd	Peptide compounds and therapeutic uses of same
CA3104780A1 (fr)	2018-07-11	2020-01-16	Kahr Medical Ltd.	Proteine de fusion du variant de sirpalpha-4-1bbl et procedes d'utilisation associes
CN112823208A (zh)	2018-07-31	2021-05-18	科弗朗有限公司	烟草转基因事件及用于检测与使用烟草转基因事件的方法
IL261156A (en)	2018-08-14	2020-02-27	Fass Deborah	Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
JP2021535100A (ja)	2018-08-24	2021-12-16	イェダリサーチアンドディベロップメントカンパニーリミテッドYeda Research And Development Co.Ltd.	Ｍ２マクロファージ極性化を調節する方法及び治療におけるその使用
WO2020058979A2 (fr)	2018-09-20	2020-03-26	Yeda Research And Development Co. Ltd.	Méthodes de traitement de la sclérose latérale amyotrophique
EP3856225A1 (fr)	2018-09-25	2021-08-04	BioLineRx Ltd.	Procédés de sélection d'un traitement contre un cancer associé aux récepteurs cxcr4
IL262658A (en)	2018-10-28	2020-04-30	Memorial Sloan Kettering Cancer Center	Prevention of age related clonal hematopoiesis and diseases associated therewith
IL263184A (en)	2018-11-21	2020-05-31	Yarden Yosef	Method of treating cancer and compositions for same
US12441776B2 (en)	2018-11-30	2025-10-14	Eirgen Pharma Ltd.	Oxyntomodulin peptide analog formulations
US12478571B2 (en)	2018-12-17	2025-11-25	Pontis Biologics, Inc.	Enzyme based compositions and methods for removing dental calculi
WO2020152686A1 (fr)	2019-01-23	2020-07-30	Yeda Research And Development Co. Ltd.	Milieux de culture pour cellules souches pluripotentes
SG11202107720UA (en)	2019-01-31	2021-08-30	Agency Science Tech & Res	Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
IL264768A (en)	2019-02-10	2020-08-31	Sagi Irit	Anti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof
IL264854A (en)	2019-02-14	2020-08-31	Bahat Anat	Spt5 inhibitors and methods of use thereof
JP2022521010A (ja)	2019-02-21	2022-04-04	イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレムリミテッド	薬物誘導性腎毒性を減少させるための方法
EP3927807A1 (fr)	2019-02-21	2021-12-29	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
MX2021010611A (es)	2019-03-05	2021-11-12	The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo	Aves con genoma editado.
WO2020185763A1 (fr)	2019-03-11	2020-09-17	Memorial Sloan Kettering Cancer Center	Anticorps cd22 et leurs procédés d'utilisation
GB201903519D0 (en)	2019-03-14	2019-05-01	Tropic Biosciences Uk Ltd	Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
GB201903521D0 (en)	2019-03-14	2019-05-01	Tropic Biosciences Uk Ltd	No title
GB201903520D0 (en)	2019-03-14	2019-05-01	Tropic Biosciences Uk Ltd	Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
IL265486A (en)	2019-03-19	2020-09-30	Yeda Res & Dev	Bistable type ii opsins and uses thereof
WO2020194317A1 (fr)	2019-03-28	2020-10-01	Yeda Research And Development Co. Ltd.	Méthode de traitement de troubles liés aux lipides
EP3946611A2 (fr)	2019-03-31	2022-02-09	Yeda Research and Development Co. Ltd	Composés anti-viraux et anti-tumoraux
IL266433B (en)	2019-05-02	2020-11-30	Sagi Irit	Preparations containing the propeptide of lysyl oxidase and their uses
EP3969619A1 (fr)	2019-05-13	2022-03-23	Yeda Research and Development Co. Ltd	Biomarqueurs de micro-adn acellulaire pour le pronostic et le diagnostic de maladies neurodégénératives
IL266728B (en)	2019-05-19	2020-11-30	Yeda Res & Dev	Identification of recurrent mutant neopeptides
CA3140611A1 (fr)	2019-05-22	2020-11-26	Hadasit Medical Research Services And Development Ltd.	Procedes de culture de cellules pluripotentes humaines
US20220251179A1 (en)	2019-05-28	2022-08-11	Shanghaitech University	Composition and methods to treat ectodermal dysplasia 2, clouston type
WO2020250232A1 (fr)	2019-06-12	2020-12-17	Hadasit Medical Research Services And Development Ltd.	Procédés de génération d'oligodendrocytes
US12516313B2 (en)	2019-06-16	2026-01-06	Yeda Research And Development Co. Ltd.	Method for stabilizing intracellular RNA
WO2020261281A1 (fr)	2019-06-27	2020-12-30	Ramot At Tel-Aviv University Ltd.	Anticorps semaphorine 3a et leurs utilisations
KR20220042139A (ko)	2019-07-04	2022-04-04	유코 아이엔씨.	에피토프 제거된 알파 글리아딘 및 복강병 및 글루텐 민감성의 관리를 위한 이의 용도
EP3997114A1 (fr)	2019-07-11	2022-05-18	KAHR Medical Ltd.	Hétérodimères et procédés d'utilisation correspondants
US20220281960A1 (en)	2019-07-16	2022-09-08	Ramot At Tel-Aviv University Ltd.	Compositions and methods for the treatment of tuberculosis
IL268111A (en)	2019-07-16	2021-01-31	Fainzilber Michael	Methods of treating pain
EP4004548B1 (fr)	2019-07-29	2026-01-14	Yeda Research and Development Co. Ltd	Procédés de traitement et de diagnostic du cancer du poumon
CA3148950A1 (fr)	2019-07-30	2021-02-04	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center	Methodes de regulation de la synthese de cannabinoides chez la plante ou dans des cellules et plantes et cellules ainsi produites
WO2021028909A1 (fr)	2019-08-12	2021-02-18	Yeda Research And Development Co. Ltd.	Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
WO2021033176A1 (fr)	2019-08-22	2021-02-25	Ariel Scientific Innovations Ltd.	Procédés mis à l'échelle de purification d'anticorps
EP4021463A1 (fr)	2019-08-27	2022-07-06	Yeda Research and Development Co. Ltd	Traitement de la vaginose bactérienne
WO2021048852A1 (fr)	2019-09-11	2021-03-18	Yeda Research And Development Co. Ltd.	Méthodes de traitement du cancer du sein
IL269674B (en)	2019-09-25	2020-08-31	Roy Bar Ziv	Assembling protein complexes on a chip
IL270306A (en)	2019-10-30	2021-05-31	Yeda Res & Dev	Prevention and treatment of pre-myeloid and myeloid malignancies
EP4051695A1 (fr)	2019-10-31	2022-09-07	Yeda Research and Development Co., Ltd.	Bactéries autotrophes génétiquement modifiées pour la conversion de co2 en matériaux organiques
AU2020384953A1 (en)	2019-11-11	2022-06-23	Ibi-Ag Innovative Bio Insecticides Ltd.	Insect control nanobodies and uses thereof
WO2021100034A1 (fr)	2019-11-19	2021-05-27	Protalix Ltd.	Élimination de constructions à partir de cellules transformées
IL270800A (en)	2019-11-20	2021-05-31	Yeda Res & Dev	A method for treating Alzheimer's disease
EP4077731A1 (fr)	2019-12-22	2022-10-26	Yeda Research and Development Co. Ltd	Diagnostic de la démence frontotemporale
IL271656A (en)	2019-12-22	2021-06-30	Yeda Res & Dev	System and methods for identifying cells that have undergone genome editing
IL271778A (en)	2019-12-31	2021-06-30	Ichilov Tech Ltd	Methods for treating atopic dermatitis
US20230048361A1 (en)	2019-12-31	2023-02-16	Kahr Medical Ltd.	Methods of culturing t cells and uses of same
WO2021137231A1 (fr)	2019-12-31	2021-07-08	Kahr Medical Ltd.	Procédés de culture de lymphocytes t avec un polypeptide de fusion 4-1bbl et leurs utilisations
IL272074B2 (en)	2020-01-15	2024-12-01	Immunity Pharma Ltd	Peptide compounds and methods of treating diseases using same
IL272194A (en)	2020-01-22	2021-07-29	Yeda Res & Dev	Multispecific antibodies for use in treating diseases
WO2021152584A1 (fr)	2020-01-28	2021-08-05	Ariel Scientific Innovations Ltd.	Procédés d'analyse de membranes cellulaires
EP4484956A3 (fr)	2020-01-29	2025-07-16	MeMed Diagnostics Ltd.	Procédés de diagnostic et de classification d'infections virales
WO2021152587A1 (fr)	2020-01-30	2021-08-05	Yeda Research And Development Co. Ltd.	Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
IL272389A (en)	2020-01-30	2021-08-31	Yeda Res & Dev	Kits containing antibodies to PD-L1 and their uses in therapy
WO2021152586A1 (fr)	2020-01-30	2021-08-05	Yeda Research And Development Co. Ltd.	Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
IL272390A (en)	2020-01-30	2021-08-31	Yeda Res & Dev	Cancer treatment methods
EP4097244A2 (fr)	2020-02-09	2022-12-07	NLC Pharma Ltd	Test de détection rapide du sras-cov-2
IL272586A (en)	2020-02-10	2021-08-31	Yeda Res & Dev	A method for cell cluster analysis
WO2021173674A1 (fr)	2020-02-26	2021-09-02	A2 Biotherapeutics, Inc.	Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
US20230127559A1 (en)	2020-03-16	2023-04-27	Yeda Research And Development Co. Ltd.	Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
BR112022019510A2 (pt)	2020-03-29	2022-11-16	Yeda Res & Dev	Variantes de beta-glucocerebrosidase para uso no tratamento de doença de gaucher
CN115484836A (zh)	2020-03-31	2022-12-16	百欧穆斯有限公司	用于预防和治疗烟雾诱发的肺部损伤的细菌
WO2021205444A1 (fr)	2020-04-06	2021-10-14	Yeda Research And Development Co. Ltd.	Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
WO2021205459A1 (fr)	2020-04-07	2021-10-14	Ramot At Tel-Aviv University Ltd.	Compositions contenant du cannabidiol et leurs utilisations
US20230135456A1 (en)	2020-04-13	2023-05-04	Exoprother Medical Ltd.	Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
US20210322483A1 (en)	2020-04-16	2021-10-21	Ichilov Tech Ltd.	Cell-derived particles presenting heterologous cd24 and use thereof in therapy
WO2021229577A1 (fr)	2020-05-12	2021-11-18	Collplant Ltd.	Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
IL274811B (en)	2020-05-20	2021-05-31	Yeda Res & Dev	Spatial information is developed for the analysis of individual cells
US20230220459A1 (en)	2020-06-10	2023-07-13	Ramot At Tel-Aviv University Ltd.	METHODS OF DETECTING METHYLATED CpG
CN116194575A (zh)	2020-06-22	2023-05-30	拉莫特特拉维夫大学有限公司	多亚基蛋白质组件、表达多亚基蛋白质组件的细胞及其用途
WO2021260675A1 (fr)	2020-06-24	2021-12-30	Yeda Research And Development Co. Ltd.	Agents pour sensibiliser des tumeurs solides à un traitement
IL276599A (en)	2020-08-09	2022-03-01	Yeda Res & Dev	T cell receptor unique to mage-a1 and its uses
IL276627A (en)	2020-08-10	2022-03-01	Yeda Res & Dev	Compositions for diagnosis and treatment of coronavirus infections
EP4199703A1 (fr)	2020-08-18	2023-06-28	International Rice Research Institute	Procédés d'augmentation des taux de croisement de gramineae
EP4228656A4 (fr)	2020-08-18	2024-09-04	Yeda Research and Development Co. Ltd	Composés anti-viraux et anti-tumoraux
IL277488A (en)	2020-09-21	2022-04-01	Yeda Res & Dev	Weight regulation method
WO2022064494A2 (fr)	2020-09-23	2022-03-31	Yeda Research And Development Co. Ltd.	Méthodes et compositions pour traiter des infections à coronavirus
IL277743A (en)	2020-10-01	2022-04-01	Yeda Res & Dev	A method for diagnosing breast cancer
JP2023545999A (ja)	2020-10-05	2023-11-01	プロタリクスリミテッド	ダイサー（ｄｉｃｅｒ）様ノックアウト植物細胞
IL301970A (en)	2020-10-07	2023-06-01	Protalix Ltd	Long-acting dnase
EP4228637A1 (fr)	2020-10-15	2023-08-23	Yeda Research and Development Co. Ltd	Méthode de traitement des cancers myéloïdes
IL278401A (en)	2020-10-29	2022-05-01	Yeda Res & Dev	Polynucleotides for editing RNA and a method for using them
US20230416750A1 (en)	2020-11-09	2023-12-28	1E Therapeutics Ltd.	Catalytic sequence based methods of treating or preventing bacterial infections
US20230416314A1 (en)	2020-11-26	2023-12-28	Ukko Inc.	Modified high molecular weight glutenin subunit and uses thereof
IL279559A (en)	2020-12-17	2022-07-01	Yeda Res & Dev	Controlling ubiquitination of mlkl for treatment of disease
WO2022144882A2 (fr)	2020-12-28	2022-07-07	1E Therapeutics, Ltd.	Zones cibles de l'arnm p21 pour le silençage
WO2022144883A2 (fr)	2020-12-28	2022-07-07	1E Therapeutics, Ltd.	Arnm de p21 ciblant des dnazymes
EP4274886A2 (fr)	2021-01-10	2023-11-15	Supermeat the Essence of Meat Ltd.	Agrégats de cellules souches pluripotentes et microtissus obtenus à partir de ceux-ci pour l'industrie de la viande cultivée
WO2022153286A1 (fr)	2021-01-14	2022-07-21	Yeda Research And Development Co. Ltd.	Procédés de production de vitamine d
IL280340B (en)	2021-01-21	2022-04-01	Yeda Res & Dev	Antibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection
JP2024506954A (ja)	2021-02-18	2024-02-15	イェダリサーチアンドデベロップメントカンパニーリミテッド	ワクチン作製用の遺伝子改変細菌
IL305315A (en)	2021-02-18	2023-10-01	Yeda res & development co ltd	Methods for producing vaccines
IL281561A (en)	2021-03-16	2022-10-01	Yeda Res & Dev	Methods and devices for ex-utero mouse embryonic development
AU2022247325A1 (en)	2021-03-30	2023-10-05	Biomx Ltd.	Pseudomonas bacteriophage and uses thereof
IL282188A (en)	2021-04-08	2022-11-01	Yeda Res & Dev	Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
CA3218291A1 (fr)	2021-05-12	2022-11-17	Lior Moshe ZELCBUCH	Bacteriophage de staphylococcus et ses utilisations
IL283563A (en)	2021-05-30	2022-12-01	Yeda Res & Dev	Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
IL309061A (en)	2021-06-06	2024-02-01	Yeda res & development co ltd	Combined cancer treatment
EP4355857A1 (fr)	2021-06-13	2024-04-24	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Procédé de reprogrammation de cellules humaines
NL2028466B1 (en)	2021-06-16	2022-12-21	Sakata Holland B V	Methods of sorting matthiola seeds
MX2023015233A (es)	2021-06-16	2024-01-31	Seedx Tech Inc	Metodos de clasificacion de semillas de matthiola.
KR20240031315A (ko)	2021-07-02	2024-03-07	트로픽 바이오사이언시즈 유케이 리미티드	바나나 과실의 갈변 지연 또는 예방
WO2023286059A1 (fr)	2021-07-13	2023-01-19	Technion Research & Development Foundation Limited	Compositions et méthodes de traitement d'un état de santé
US20250283052A1 (en)	2021-07-18	2025-09-11	Gamida Cell Ltd.	Therapeutic nk cell populations
WO2023002492A1 (fr)	2021-07-22	2023-01-26	Yeda Research And Development Co. Ltd.	Optimisation de codon d'acides nucléiques
US20250066447A1 (en)	2021-08-03	2025-02-27	Genicity Limited	Engineered tcr complex and methods of using game
EP4130028A1 (fr)	2021-08-03	2023-02-08	Rhazes Therapeutics Ltd	Complexe tcr modifié et leurs procédés d'utilisation
EP4384603A1 (fr)	2021-08-10	2024-06-19	Gamida-Cell Ltd.	Cellules nk modifiées, leurs procédés de production et leurs utilisations
GB202112865D0 (en)	2021-09-09	2021-10-27	Tropic Biosciences Uk Ltd	Resistance to black sigatoka disease in banana
GB202112866D0 (en)	2021-09-09	2021-10-27	Tropic Biosciences Uk Ltd	Resistance to fusarium wilt in a banana
IL286430A (en)	2021-09-14	2023-04-01	Yeda Res & Dev	Multispecific antibodies for use in the treatment of diseases
AU2022404031A1 (en)	2021-12-08	2024-07-25	Board Of Regents, The University Of Texas System	Multipotent lung progenitor cells for lung regeneration
EP4499108A1 (fr)	2022-04-25	2025-02-05	Yeda Research and Development Co. Ltd	Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
WO2025150045A1 (fr)	2024-01-12	2025-07-17	Gabriel Nussbaum	Cibles bactériennes, agents thérapeutiques, compositions, kits et procédés d'utilisation dans le traitement et/ou la prévention du cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3592888A (en) *	1968-01-19	1971-07-13	Mount Sinai Hospital Research	Radioimmunoassay of angiotensin and renin activity
US3646346A (en) *	1968-12-26	1972-02-29	Pharmacia Ab	Antibody-coated tube system for radioimmunoassay

1971
- 1971-12-21 US US210510A patent/US3867517A/en not_active Expired - Lifetime
1972
- 1972-12-12 CA CA158,644A patent/CA988420A/en not_active Expired
- 1972-12-13 ZA ZA728798A patent/ZA728798B/xx unknown
- 1972-12-18 AU AU50214/72A patent/AU470050B2/en not_active Expired
- 1972-12-18 PH PH14185A patent/PH13655A/en unknown
- 1972-12-19 GB GB5866272A patent/GB1414480A/en not_active Expired
- 1972-12-19 FR FR7245321A patent/FR2164705B1/fr not_active Expired
- 1972-12-20 DE DE19722262413 patent/DE2262413B2/de not_active Ceased
- 1972-12-20 IT IT54886/72A patent/IT988084B/it active
- 1972-12-20 CH CH1856372A patent/CH568061A5/xx not_active IP Right Cessation
- 1972-12-20 CH CH1026375A patent/CH589445A5/xx not_active IP Right Cessation
- 1972-12-20 BE BE793061A patent/BE793061A/fr unknown
- 1972-12-20 NL NL7217371A patent/NL7217371A/xx active Search and Examination
- 1972-12-20 AT AT1088772A patent/AT326818B/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
NL7217371A (fr)	1973-06-25
FR2164705A1 (fr)	1973-08-03
GB1414480A (en)	1975-11-19
ZA728798B (en)	1974-02-27
DE2262413B2 (de)	1977-11-17
IT988084B (it)	1975-04-10
ATA1088772A (de)	1975-03-15
CH589445A5 (fr)	1977-07-15
AU5021472A (en)	1974-06-20
PH13655A (en)	1980-08-21
DE2262413A1 (de)	1973-07-05
BE793061A (fr)	1973-06-20
AU470050B2 (en)	1974-06-20
US3867517A (en)	1975-02-18
AT326818B (de)	1975-12-29
FR2164705B1 (fr)	1976-10-29
CH568061A5 (fr)	1975-10-31

Publication	Publication Date	Title
AU470050B2 (en)	1974-06-20	Direct radioimmunoassay for antigens and their antibodies
CA988419A (en)	1976-05-04	Test apparatus for direct radioimmunoassay for antigens and their antibodies
CA956889A (en)	1974-10-29	Barbituric acid antigens
IL42508A0 (en)	1973-08-29	The preparation of antiserum specific for carcinoembryonic antigen
CA988767A (en)	1976-05-11	Electrophotographic material
CA1018236A (fr)	1977-09-27	Methode d'electrophotographie
AU462407B2 (en)	1975-06-26	Mite antigen and method for manufacture
CA966778A (en)	1975-04-29	Antigens and antibodies
CA967817A (en)	1975-05-20	Electrophotography
CA951899A (en)	1974-07-30	Material and method for enhancing combustion
CA981965A (en)	1976-01-20	Electrophotographic material
CA977096A (en)	1975-10-28	Photoconductor and process for the preparation thereof
AU458838B2 (en)	1975-02-20	Method of manifold copying
AU460448B2 (en)	1975-04-09	Preparation of thymocyte antigens, and of anti-thymocytary serums and gamma-globulins
CA980337A (en)	1975-12-23	Hapten and antigen derivatives
CA887021A (en)	1971-11-30	Electrophotography
CA864462A (en)	1971-02-23	Electrophotographic method and member
CA871073A (en)	1971-05-18	Xerographic plate and method
CA1022923A (en)	1977-12-20	Antigens
CA864577A (en)	1971-02-23	Organosulfonylalkylsilanes and methods for making them
CA834128A (en)	1970-02-10	Method of preparing antibodies
CA883252A (en)	1971-10-12	Immunological method
CA937278A (en)	1973-11-20	Method of manifold copying
CA874911A (en)	1971-07-06	Photoelectrostatic developing material
CA842760A (en)	1970-05-26	Stabilized antigens and means for the production thereof